Logo: to the web site of Uppsala University

uu.sePublications from Uppsala University
Change search
Refine search result
1 - 44 of 44
CiteExportLink to result list
Permanent link
Cite
Citation style
  • apa
  • ieee
  • modern-language-association
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Rows per page
  • 5
  • 10
  • 20
  • 50
  • 100
  • 250
Sort
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
  • Standard (Relevance)
  • Author A-Ö
  • Author Ö-A
  • Title A-Ö
  • Title Ö-A
  • Publication type A-Ö
  • Publication type Ö-A
  • Issued (Oldest first)
  • Issued (Newest first)
  • Created (Oldest first)
  • Created (Newest first)
  • Last updated (Oldest first)
  • Last updated (Newest first)
  • Disputation date (earliest first)
  • Disputation date (latest first)
Select
The maximal number of hits you can export is 250. When you want to export more records please use the Create feeds function.
  • 1.
    Al-Hammadi, Mustafa
    et al.
    Dalarna Univ, Sch Informat & Engn, S-79131 Falun, Sweden..
    Fleyeh, Hasan
    Dalarna Univ, Sch Informat & Engn, S-79131 Falun, Sweden..
    Åberg, Anna Cristina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Dalarna Univ, Sch Hlth & Welf, Falun, Sweden.
    Halvorsen, Kjartan
    Dalarna Univ, Sch Hlth & Welf, Falun, Sweden..
    Thomas, Ilias
    Dalarna Univ, Sch Informat & Engn, S-79131 Falun, Sweden..
    Machine Learning Approaches for Dementia Detection Through Speech and Gait Analysis: A Systematic Literature Review2024In: Journal of Alzheimer's Disease, ISSN 1387-2877, E-ISSN 1875-8908, Vol. 100, no 1, p. 1-27Article, review/survey (Refereed)
    Abstract [en]

    Background:

    Dementia is a general term for several progressive neurodegenerative disorders including Alzheimer’s disease. Timely and accurate detection is crucial for early intervention. Advancements in artificial intelligence present significant potential for using machine learning to aid in early detection.

    Objective:

    Summarize the state-of-the-art machine learning-based approaches for dementia prediction, focusing on non-invasive methods, as the burden on the patients is lower. Specifically, the analysis of gait and speech performance can offer insights into cognitive health through clinically cost-effective screening methods.

    Methods:

    A systematic literature review was conducted following the PRISMA protocol (Preferred Reporting Items for Systematic Reviews and Meta-Analyses). The search was performed on three electronic databases (Scopus, Web of Science, and PubMed) to identify the relevant studies published between 2017 to 2022. A total of 40 papers were selected for review.

    Results:

    The most common machine learning methods employed were support vector machine followed by deep learning. Studies suggested the use of multimodal approaches as they can provide comprehensive and better prediction performance. Deep learning application in gait studies is still in the early stages as few studies have applied it. Moreover, including features of whole body movement contribute to better classification accuracy. Regarding speech studies, the combination of different parameters (acoustic, linguistic, cognitive testing) produced better results.

    Conclusions:

    The review highlights the potential of machine learning, particularly non-invasive approaches, in the early prediction of dementia. The comparable prediction accuracies of manual and automatic speech analysis indicate an imminent fully automated approach for dementia detection.

    Download full text (pdf)
    fulltext
  • 2.
    Ali, Mohamed K.
    et al.
    School of Health and Welfare Dalarna University Falun Sweden;Research Evaluation, Accountability, Learning and Monitoring (REALM) Save the Children International Somalia Country Office Mogadishu Somalia.
    Berglund, Lars
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. School of Health and Welfare Dalarna University Falun Sweden;Epistat AB Uppsala Sweden.
    Flacking, Renée
    School of Health and Welfare Dalarna University Falun Sweden.
    Sulaiman, Munshi
    Research Evaluation, Accountability, Learning and Monitoring (REALM) Save the Children International Somalia Country Office Mogadishu Somalia.
    Osman, Fatumo
    School of Health and Welfare Dalarna University Falun Sweden.
    Dietary diversity and associated factors among households and children in internally displaced person camps in Southern Somalia: A cross‐sectional study2024In: Maternal and Child Nutrition, ISSN 1740-8695, E-ISSN 1740-8709, Vol. 20, no 4, article id e13707Article in journal (Refereed)
    Abstract [en]

    The study aimed to assess household and child dietary diversity in Southern Somalia by identifying determinants of adequate dietary diversity in three internally displaced person (IDP) camps in Baidoa, Dayniile and Dharkanley. A total of 1655 female main caregivers with 2370 children (6-59 months old) were included. Data on household dietary diversity score and child dietary diversity score indicators were collected from all households. The questionnaire was read face-to-face to the female main caregivers. Multivariate logistic regression analysis was performed to identify factors associated with adequate dietary diversity, which was defined as the consumption of at least four food groups within 24 h before the survey. The proportion of households achieving adequate HDDS was high in all locations 95.8%, 96.9% and 89.0% in Baidoa, Dharkanley and Dayniile, respectively, and the total adequate household dietary diversity score (AHDDS) was 95.6%. The proportion of adequate child dietary diversity score (ACDDS) was achieved in 63.5%, 8.5% and 38.3%. The main factors associated with AHDDS were larger household size, greater wealth, attendance of antenatal care (ANC) and joint decision-making between husband and wife, while factors associated with ACDDS included ANC attendance, age, the consumption of ready-to-use therapeutic food and deworming tablets. These findings can guide future programmes and policies aimed at improving maternal and child nutrition in IDP camps in Somalia. By tackling these diverse factors, a promising pathway emerges to enhance the nutritional welfare of both households and children in IDP camps. 

    Download full text (pdf)
    fulltext
  • 3.
    Ballin, Marcel
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden..
    Enelius, Moa Backman
    Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden..
    Dini, Samira
    Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden..
    Galanti, Maria Rosaria
    Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden..
    Hagstromer, Maria
    Karolinska Inst, Div Physiotherapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden.;Reg Stockholm, Acad Primary Hlth Care Ctr, Stockholm, Sweden.;Sophiahemmet Univ, Dept Hlth Promoting Sci, Stockholm, Sweden..
    Heintz, Emelie
    Reg Stockholm, Stockholm Ctr Hlth Econ, Stockholm, Stockholm, Sweden.;Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden..
    Lager, Anton
    Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden.;Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden..
    de Leon, Antonio Ponce
    Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden.;Karolinska Inst, Dept Global Publ Hlth, Stockholm, Sweden..
    Lundh, Lena
    Reg Stockholm, Acad Primary Hlth Care Ctr, Stockholm, Sweden.;Karolinska Inst, Div Family Med & Primary Care, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden..
    Nystrand, Camilla
    Reg Stockholm, Stockholm Ctr Hlth Econ, Stockholm, Stockholm, Sweden.;Karolinska Inst, Dept Learning Informat Management & Eth, Stockholm, Sweden..
    Walldin, Christina
    Reg Stockholm, Acad Primary Hlth Care Ctr, Stockholm, Sweden..
    Augustsson, Hanna
    Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden.;Karolinska Inst, Med Management Ctr, Dept Learning Informat Management & Eth, Procome Res Grp, Stockholm, Sweden..
    Health dialogue intervention versus opportunistic screening in primary care for type 2 diabetes and cardiovascular disease prevention in settings with low socioeconomic status (DETECT): study protocol for a pragmatic cluster-randomized trial2024In: Trials, E-ISSN 1745-6215, Vol. 25, no 1, article id 672Article in journal (Refereed)
    Abstract [en]

    Background Meta-analyses of randomized trials suggest that health checks and health promotion interventions targeting behavior change in primary care do not prevent cardiovascular morbidity and mortality in the general population. However, whether such interventions are more effective in high-risk populations, such as people living in low socioeconomic settings, remains unclear, as they have been poorly represented in previous trials. Therefore, we aim to evaluate the effectiveness, cost-effectiveness, and implementation of systematic screening followed by an individually oriented, lifestyle-focused, health dialogue intervention for prevention of type 2 diabetes and cardiovascular disease, as compared to opportunistic screening, in primary care in socioeconomically disadvantaged areas.

    Methods Using an overall pragmatic approach and a cluster-randomized design with two arms, we aim to enroll 3000 participants aged 50-59 years from 30 primary care centers (PCCs) with an above-average level of Care Need Index in Stockholm Region, Sweden. PCCs will be randomized (1:1) either to a health dialogue intervention, which includes inviting enlisted patients to a systematic screening of risk factors followed by an individually oriented lifestyle-focused health dialogue, or to opportunistic screening, which includes screening patients for a smaller set of risk factors during an appointment at their PCC taking place for other reasons. The main outcome will be change in systolic blood pressure during 6- and 12-month follow-ups. Additional short-term outcomes will be changes in other biological risk factors, health-related quality-of-life, and lifestyle habits, as well as process and implementation outcomes, and unintended side effects. The long-term effect on type 2 diabetes and cardiovascular disease incidence and mortality will be examined using regional and nationwide registers. Changes in systolic blood pressure and other health outcomes will be analyzed using mixed-effect generalized linear modeling and mixed-effect Cox regression to capture variability between and within PCCs. A health economic evaluation will assess resource use and costs in the short- and long-term.

    Discussion This trial of lifestyle-focused health dialogues and opportunistic screening in primary care in socioeconomically disadvantaged areas in the largest region of Sweden has the potential to yield valuable insights that could support evidence-based policymaking.Trial registrationClinicalTrials.gov (NCT06067178). Prospectively registered September 27, 2023.

    Download full text (pdf)
    FULLTEXT01
  • 4.
    Ballin, Marcel
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden.
    Neovius, Martin
    Department of Medicine, Clinical Epidemiology Division, Karolinska Institutet, Stockholm, Sweden.
    Ortega, Francisco B.
    Department of Physical Education and Sports, Faculty of Sport Sciences, Sport and Health University Research Institute, University of Granada, Granada, Spain;Faculty of Sport and Health Sciences, University of Jyväskylä, Jyväskylä, Finland;CIBER de Fisiopatología de la Obesidad y Nutrición, Instituto de Salud Carlos III, Granada, Spain.
    Henriksson, Pontus
    Department of Health, Medicine and Caring Sciences, Linköping University, Linköping, Sweden.
    Nordström, Anna
    Rehabilitation and Pain Centre, Uppsala University Hospital, Uppsala, Sweden; School of Sport Sciences, UiT the Arctic University of Norway, Tromsø, Norway; Department of Health Sciences, The Swedish Winter Sport Research Centre, Mid Sweden University, Östersund, Sweden.
    Berglind, Daniel
    Centre for Epidemiology and Community Medicine, Region Stockholm, Stockholm, Sweden;Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Ahlqvist, Viktor H.
    Department of Global Public Health, Karolinska Institutet, Stockholm, Sweden.
    Genetic and Environmental Factors and Cardiovascular Disease Risk in Adolescents2023In: JAMA Network Open, E-ISSN 2574-3805, Vol. 6, no 11, article id e2343947Article in journal (Refereed)
    Abstract [en]

    Importance  Cardiovascular risk factors in youth have been associated with future cardiovascular disease (CVD), but conventional observational studies are vulnerable to genetic and environmental confounding.

    Objective  To examine the role of genetic and environmental factors shared by full siblings in the association of adolescent cardiovascular risk factors with future CVD.

    Design, Setting, and Participants  This is a nationwide cohort study with full sibling comparisons. All men who underwent mandatory military conscription examinations in Sweden between 1972 and 1995 were followed up until December 31, 2016. Data analysis was performed from May 1 to November 10, 2022.

    Exposures  Body mass index (BMI), cardiorespiratory fitness, blood pressure, handgrip strength, and a combined risk z score in late adolescence.

    Main Outcomes and Measures  The primary outcome was fatal or nonfatal CVD, as recorded in the National Inpatient Register or the Cause of Death Register before 2017.

    Results  A total of 1 138 833 men (mean [SD] age, 18.3 [0.8] years), of whom 463 995 were full brothers, were followed up for a median (IQR) of 32.1 (26.7-37.7) years, during which 48 606 experienced a CVD outcome (18 598 among full brothers). All risk factors were associated with CVD, but the effect of controlling for unobserved genetic and environmental factors shared by full siblings varied. In the sibling analysis, hazard ratios for CVD (top vs bottom decile) were 2.10 (95% CI, 1.90-2.32) for BMI, 0.77 (95% CI, 0.68-0.88) for cardiorespiratory fitness, 1.45 (95% CI, 1.32-1.60) for systolic blood pressure, 0.90 (95% CI, 0.82-0.99) for handgrip strength, and 2.19 (95% CI, 1.96-2.46) for the combined z score. The percentage attenuation in these hazard ratios in the sibling vs total cohort analysis ranged from 1.1% for handgrip strength to 40.0% for cardiorespiratory fitness. Consequently, in the sibling analysis, the difference in cumulative CVD incidence at age 60 years (top vs bottom decile) was 7.2% (95% CI, 5.9%-8.6%) for BMI and 1.8% (95% CI, 1.0%-2.5%) for cardiorespiratory fitness. Similarly, in the sibling analysis, hypothetically shifting everyone in the worst deciles of BMI to the middle decile would prevent 14.9% of CVD at age 60 years, whereas the corresponding number for cardiorespiratory fitness was 5.3%.

    Conclusions and Relevance  In this Swedish national cohort study, cardiovascular risk factors in late adolescence, especially a high BMI, were important targets for CVD prevention, independently of unobserved genetic and environmental factors shared by full siblings. However, the role of adolescent cardiorespiratory fitness in CVD may have been overstated by conventional observational studies.

    Download full text (pdf)
    fulltext
  • 5.
    Basun, Hans
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Nya antikroppsbehandlingar mot Alzheimers sjukdom: BEHOV AV NATIONELL FÖRBEREDELSE OCH SAMORDNING2024In: Läkartidningen, ISSN 0023-7205, E-ISSN 1652-7518, Vol. 121Article in journal (Refereed)
  • 6.
    Basun, Hans
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Kilander, Lena
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Kognitiva sjukdomar2024In: Psykiatri / [ed] Jörgen Herlofson, Studentlitteratur AB, 2024Chapter in book (Other academic)
  • 7.
    Blomberg, Oscar
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    Svedin, Frida
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    Farrand, Paul
    Clinical Education Development and Research (CEDAR), University of Exeter, Exeter, UK.
    Brantnell, Anders
    Uppsala University, Disciplinary Domain of Science and Technology, Technology, Department of Civil and Industrial Engineering, Industrial Engineering and Management. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    von Essen, Louise
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    Patriksson Karlsson, Johanna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    Åberg, Anna Cristina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Woodford, Joanne
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Healthcare Sciences and e-Health.
    Adaptation of a guided low-intensity behavioral activation intervention for people with dementia in Sweden: a qualitative study exploring the needs and preferences of key stakeholders2024In: BMC Geriatrics, E-ISSN 1471-2318, Vol. 24, no 113Article in journal (Refereed)
    Abstract [en]

    Background

    Despite depression being prevalent in people with dementia, contributing to negative health outcomes and placing increased burden on individuals and family members, access to psychological interventions is limited. A potential solution is guided low-intensity behavioral activation, supported by informal caregivers and guided by healthcare professionals. However, it is necessary to adapt interventions to meet the needs and preferences of key stakeholders to enhance acceptability and relevance. Study objectives were to: (1) explore needs and preferences concerning the content and delivery model of the guided low-intensity behavioral activation intervention; and (2) adapt the intervention to ensure cultural appropriateness, relevancy, and acceptability to people with dementia and their caregivers in Sweden.

    Methods

    Semi-structured interviews and focus group discussions were conducted with key stakeholders, including healthcare professionals (n = 18), community stakeholders (n = 7), people with dementia (n = 8), and informal caregivers (n = 19). A draft of the written low-intensity behavioral activation intervention and a description of the proposed intervention delivery model were provided to participants. Open-ended questions explored the perceived relevance of the intervention, alongside needs and preferences concerning content and delivery. A manifest content analysis approach was adopted.

    Results

    Content analysis resulted in three categories: Content, Delivery procedures, and Illness trajectory. Results highlighted a need to consider the intervention Content via increased cultural adaptation to the Swedish context, and increasing the inclusiveness of intervention content. Delivery procedures were identified as needing to be flexible given the unpredictable nature of caring for people with dementia, with the provision of additional guidance to informal caregivers supporting the intervention. Illness trajectory was viewed as essential to consider, with the intervention regarded as suitable for those early in the dementia trajectory, alongside a need to reduce workbook text to minimize burden given dementia symptomology.

    Conclusions

    The intervention and proposed delivery model were generally well received by all stakeholders. We were able to identify key adaptations to enhance cultural appropriateness, relevancy, and acceptability for a currently neglected population. Results will inform a feasibility study to explore the feasibility and acceptability of the intervention and study procedures to inform the design of a future superiority randomized controlled trial.

    Download full text (pdf)
    fulltext
  • 8.
    Blomberg, Oscar
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    Svedin, Frida
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    Farrand, Paul
    University of Exeter.
    Brantnell, Anders
    Uppsala University, Disciplinary Domain of Science and Technology, Technology, Department of Civil and Industrial Engineering, Industrial Engineering and Management. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    von Essen, Louise
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Caring Sciences. Uppsala University, Disciplinary Domain of Humanities and Social Sciences, Faculty of Social Sciences, Department of Psychology. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    Åberg, Anna Cristina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    Woodford, Joanne
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, CIRCLE – Complex Intervention Research in Health and Care.
    Involving key stakeholders in development of a low-intensity behavioral activation intervention for people with dementia: A qualitative study2024Conference paper (Refereed)
  • 9.
    Byström, Elin
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences.
    Wennlöf, Björn
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences.
    Johansson, Inger
    NSPH, Swedish Partnership Mental Hlth Vastmanland, Västerås, Sweden..
    Lönnberg, Lena
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Arkkukangas, Marina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research Sörmland. Dalarna Univ, Dept Med Sport & Fitness Sci, Falun, Sweden.;Mälardalen Univ, Sch Hlth Care & Social Welf, Dept Physiotherapy, Västerås, Sweden..
    Pellas, Johnny
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Damberg, Mattias
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    DepActive: study protocol for a randomised controlled multicentre trial of telephone-delivered behavioural activation for the treatment of depression in older adults in primary care2024In: Trials, E-ISSN 1745-6215, Vol. 25, no 1, article id 659Article in journal (Refereed)
    Abstract [en]

    Background

    Depression is common in older adults and is related to reduced quality of life and functional ability as well as increased mortality and morbidity. Current guidelines recommend psychological treatments for the treatment of depression in adults. Studies show that about 30% of older adults with depression in Sweden receive pharmacological treatment and about 3% receive psychological treatment. However, a majority receive no treatment at all. There is a need for effective and scalable psychological treatment options for older adults with depression in primary care. Behavioural activation is an extensively evaluated, effective, and relatively simple treatment for depression that can be delivered by health care professionals without comprehensive training in psychological treatment.

    Methods

    We will conduct a randomised controlled 2-armed parallel group multicentre trial comparing treatment as usual in primary care to a five-session telephone-delivered behavioural activation treatment as add on to treatment as usual. The current trial is open labelled. In all, 250 older adults (>= 65 years) with depression will be recruited from primary healthcare centres in three Swedish regions. The primary outcome is depressive symptoms measured with the Montgomery Åsberg Depression Rating Scale - Self rating version (MADRS-S) after treatment and at 3- and 6-month follow-up. Secondary outcomes include depression diagnoses, activity level (self-rated and measured with accelerometer), and self-rated anxiety, daily functioning, quality of life, self-efficacy, and loneliness.

    Discussion

    There is a need for fully powered studies of brief behavioural activation for older adults with depression delivered by telephone in a primary care context. This study has the potential to improve first-line treatment of depression in older adults in primary care, consequently reducing morbidity and mortality within this population. Increasing the availability and accessibility to effective psychological treatment for depression in older adults is needed to meet future demographic changes.

    Trial registration

    ClinicalTrials.gov: NCT06284889. Registered February 28, 2024.

    Download full text (pdf)
    FULLTEXT01
  • 10.
    Cam, Henrik
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Franzon, Kristin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Kälvemark Sporrong, Sofia
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Kempen, Thomas Gerardus Hendrik
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands..
    Bernsten, Cecilia
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Nielsen, Elisabet I.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Gustavsson, Lovisa
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Moosavi, Elnaz
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Lindmark, Stina
    Uppsala Univ Hosp, Geriatr, Uppsala, Sweden..
    Ehlin, Ulf
    Osthammar Assoc Relat & Elderly People, Osthammar, Sweden..
    Sjoelander, Maria
    Dept Pharm, Västerås, Region Vastmanl, Sweden..
    Lindner, Karl-Johan
    Dept Pharm, Västerås, Region Vastmanl, Sweden..
    Gillespie, Ulrika
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    'You're Just Thinking About Going Home': Exploring Person-Centred Medication Communication With Older Patients at Hospital Discharge2024In: Health Expectations, ISSN 1369-6513, E-ISSN 1369-7625, Vol. 27, no 5, article id e70065Article in journal (Refereed)
    Abstract [en]

    BackgroundThe hospital discharge process poses significant safety risks for older patients due to complexities in communication and coordination among stakeholders, leading to potential drug-related problems post-discharge. Adopting a person-centred care (PCC) approach in medication communication by healthcare professionals (HCPs) is crucial to ensure positive health outcomes. This study aimed to explore the practice of PCC in medication communication between older patients and HCPs during the hospital discharge process.MethodsWe conducted a qualitative study using non-participatory direct observations of patient-HCP consultations during hospital discharge, followed by semi-structured interviews with observed patients and, when applicable, their informal caregivers. Data collection occurred from October 2020 to May 2021 at two Swedish hospitals. We gathered data using an observational form and audio-recorded all consultations and interviews. The data were analysed thematically using the systematic text condensation method.ResultsTwenty patients were included (median age: 81 years [range: 65-94]; 9 female) in observations and 13 of them participated in interviews. Two patients were accompanied by an informal caregiver during the interviews. Three main themes were identified: (1) The impact of traditional authoritarian structures, depicts power dynamics between patients and their HCPs, showing how traditional structures influence the practice of PCC in medication communication during hospital discharge; (2) Consultation timing and mode not on patients' terms, describes suboptimal times and settings for consultations, along with the use of complex language that hinders effective communication; and (3) Discrepancy in expectations of self-care ability, illustrates a mismatch between the self-care guidance provided by HCPs during hospital discharge and the actual needs and preferences of patients and informal caregivers.ConclusionMedication communication between older patients and HCPs during hospital discharge is frequently inconsistent with the practice of PCC. Not only must HCPs improve their communication strategies, but patients and their informal caregivers should also be better prepared for discharge communication and encouraged to participate in their care. This involvement would give them relevant knowledge and tailor communication to their individual needs, preventing problems in managing their medications after discharge.Patient or Public ContributionAn advisory group of six patients and/or informal caregiver contributors provided input on the study design, edited the consent forms, and helped develop the interview guide.

    Download full text (pdf)
    fulltext
  • 11.
    Cam, Henrik
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Hospital Pharmacy Department, Uppsala University Hospital, Sweden.
    Gillespie, Ulrika
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Hospital Pharmacy Department, Uppsala University Hospital, Sweden.
    Kälvemark Sporrong, Sofia
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Nielsen, Elisabet I.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Kempen, Thomas Gerardus Hendrik
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Franzon, Kristin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Failure to Involve Older Hospitalised Patients in Medication Decisions: A Change of Approach is Called For2024In: Research in Social and Administrative Pharmacy, ISSN 1551-7411, E-ISSN 1934-8150, Vol. 20, no 2, p. 216-217Article in journal (Refereed)
    Abstract [en]

    Background: Patient involvement in medical-decision making is linked to improved patient outcomes and increased patient satisfaction.

    Objectives: The aim was to explore how hospitalised older patients are and wish to be involved in medication decisions affecting their medication therapy after hospital discharge.

    Methods: Naturalistic observations of consultations between healthcare professionals and hospitalised older patients who were about to be discharged were performed at in total three medical wards at two hospitals in Sweden. Subsequent semi-structured interviews with the patients were conducted within one week after discharge. The data were thematically analysed, guided by systematic text condensation.

    Results: Twenty patients were included (mean age: 81 (SD 8) years, 45 % female). Three themes were identified: 1) Predetermined authoritarian structures; describes that neither patients nor healthcare professionals expected patients to be involved in medication decisions. The medication decisions were frequently already taken by the healthcare professionals prior to the consultations, 2) Difficulties in finding the right time and setting; displays inhibitory factors in patient involvement in medication decisions when the consultations occur in hospital, and 3) Communication focusing on benefits over side-effects; demonstrates that newly prescribed medications were rarely accompanied with information about side-effects. Patients felt they lacked sufficient knowledge to take informed decisions about medications.

    Conclusions: There are structures limiting involvement of older patients in medication decisions prior to hospital discharge. A change in approach to consultations from both the patients and healthcare professionals is needed to provide patients with the knowledge they feel is needed to be sufficiently involved.

  • 12.
    Cam, Henrik
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala Univ Hosp, Hosp Pharm Dept, Uppsala, Sweden..
    Wennlöf, Björn
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland. Narvarden Viksang Irsta, Reg Vastmanland, Västerås, Sweden..
    Gillespie, Ulrika
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Uppsala Univ Hosp, Hosp Pharm Dept, Uppsala, Sweden..
    Franzon, Kristin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Nielsen, Elisabet I.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy.
    Ling, Mia
    Reg Vastmanland, Dept Pharm, Västerås, Sweden..
    Lindner, Karl-Johan
    Reg Vastmanland, Dept Pharm, Västerås, Sweden..
    Kempen, Thomas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Univ Utrecht, Utrecht Inst Pharmaceut Sci, Utrecht, Netherlands..
    Kälvemark Sporrong, Sofia
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Pharmacy, Department of Pharmacy. Univ Copenhagen, Dept Pharm, Copenhagen, Denmark..
    The complexities of communication at hospital discharge of older patients: a qualitative study of healthcare professionals' views2023In: BMC Health Services Research, E-ISSN 1472-6963, Vol. 23, article id 1211Article in journal (Refereed)
    Abstract [en]

    Background: Hospital discharge of older patients is a high-risk situation in terms of patient safety. Due to the fragmentation of the healthcare system, communication and coordination between stakeholders are required at discharge. The aim of this study was to explore communication in general and medication information transfer in particular at hospital discharge of older patients from the perspective of healthcare professionals (HCPs) across different organisations within the healthcare system.

    Methods: We conducted a qualitative study using focus group and individual or group interviews with HCPs (physicians, nurses and pharmacists) across different healthcare organisations in Sweden. Data were collected from September to October 2021. A semi-structured interview guide including questions on current medication communication practices, possible improvements and feedback on suggestions for alternative processes was used. The data were analysed thematically, guided by the systematic text condensation method.

    Results: In total, four focus group and three semi-structured interviews were conducted with 23 HCPs. Three main themes were identified: 1) Support systems that help and hinder describes the use of support systems in the discharge process to compensate for the fragmentation of the healthcare system and the impact of these systems on HCPs' communication; 2) Communication between two separate worlds depicts the difficulties in communication experienced by HCPs in different healthcare organisations and how they cope with them; and 3) The large number of medically complex patients disrupts the communication reveals how the highly pressurised healthcare system impacts on HCPs' communication at hospital discharge.

    Conclusions: Communication at hospital discharge is hindered by the fragmented, highly pressurised healthcare system. HCPs are at risk of moral distress when coping with communication difficulties. Improved communication methods at hospital discharge are needed for the benefit of both patients and HCPs.

    Download full text (pdf)
    FULLTEXT01
  • 13.
    Emami, Azita
    et al.
    Yale School of Nursing, Yale University, PO Box 27399, West Haven, CT, 06516 USA;Division of Occupational Therapy, Department of Neurobiology, Care Sciences, and Society, Karolinska Institutet, Fack 23 200, 141 83 Huddinge, Sweden.
    Jun, Jeehye
    Red Cross College of Nursing, Chung-Ang University, 84 Heukseok-ro, Dongjak-gu, Seoul, Republic of Korea.
    Engström, Gabriella
    Florida Atlantic University, Charles E. Schmidt College of Medicine, 777 Glades Road, Boca Raton, Florida, 33431 USA.
    Berglund, Lars
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Epistat AB, Kungsängsvägen 27, 753 23 Uppsala, Sweden;School of Health and Welfare, Dalarna University, Högskolegatan 2, 791 88 Falun, Sweden.
    Theorell, Töres
    Stress Research Institute, Department of Psychology, Stockholm University, Frescativägen 8, 106 91 Stockholm, Sweden;Division of International Public Health, Karolinska Institutet, K9 GPH Ekström, 171 77 Stockholm, Sweden.
    Sample size calculations based on day-to-day variability of stress biomarkers in persons with dementia and their family caregivers2024In: BioSocial Health journal, E-ISSN 3060-6268, Vol. 1, no 3, p. 146-153Article in journal (Refereed)
    Abstract [en]

    Introduction: Accurate estimates of intra-individual variability are necessary for proper design of clinical trials and epidemiological studies where the stress biomarkers cortisol and dehydroepiandrosterone sulfate (DHEA-S) are measured for dyads of persons with dementia (PWDs) and their family caregivers (FCGs). The aim is to determine the number of consecutive sampling days required to detect effect differences in clinical trials, and to accurately estimate regression coefficients in epidemiological studies where stress biomarkers are exposure variables in regression models with future disease as outcome.

    Methods: Clinical trial data from dyads of PWDs and their FCGs were used. Salivary cortisol and DHEA-S samples were collectedfive days a week, for eight consecutive weeks. From this data, we created formulas and graphical tools for the number of required sampling days needed to detect effect differences, and we calculated number of days needed for regression coefficients to be estimated with < 10% bias.

    Results: A total of 5791 salivary samples from 34 dyads were used. For morning cortisol, five consecutive sampling days at baseline and an equal number of days at study termination is sufficient to detect a treatment difference > 5% of baseline level with > 20dyads per group. When stress biomarkers are used in epidemiological studies at least six consecutive sampling days are required.

    Conclusion: Based on a large number of consecutive measurements of stress biomarkers we calculated the sufficient numbers ofsampling days for clinical trials and for epidemiological studies to produce credible results. Our findings will aid researchers inthe study design phase.

    Download full text (pdf)
    fulltext
  • 14.
    Emami, Azita
    et al.
    Univ Washington, Sch Nursing, Dept Biobehav Nursing & Hlth Informat, Seattle, WA USA.;Karolinska Inst, Div Occupat Therapy, Dept Neurobiol Care Sci & Soc, Stockholm, Sweden..
    Jun, Jeehye
    Chung Ang Univ, Red Cross Coll Nursing, 84 Heukseok ro, Seoul 06974, South Korea..
    Theorell, Töres
    Karolinska Inst, Div Int Publ Hlth, Stockholm, Sweden.;Stockholm Univ, Stress Res Inst, Dept Psychol, Stockholm, Sweden..
    Engström, Gabriella
    Dalarna Univ, Sch Hlth & Welf, Falun, Sweden.;Florida Atlantic Univ, Charles E Schmidt Coll Med, Boca Raton, FL USA..
    Berglund, Lars
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Dalarna Univ, Sch Hlth & Welf, Falun, Sweden.;Epistat AB, Uppsala, Sweden..
    Day-to-day variability of stress biomarkers during a music intervention in people living with dementia and their family caregivers2024In: Science Progress, ISSN 0036-8504, E-ISSN 2047-7163, Vol. 107, no 3, article id 00368504241263692Article in journal (Refereed)
    Abstract [en]

    Examination of the variability of stress biomarkers among people living with dementia and their family caregivers can provide evidence of stress reactions and corresponding self-regulation capacities, but no such research has been conducted to date. The aim of this study was to examine day-to-day variability patterns of salivary biomarkers in dyads of people living with dementia and their family caregivers and to investigate differences in variability patterns between music intervention and control groups. This study involved secondary analysis of data collected during a two-group, non-randomized open trial examining the effects of an 8-week music intervention on physiological stress markers. A total of 5791 salivary samples from 34 dyads were used to analyze the variability of morning and evening cortisol and of morning dehydroepiandrosterone sulfate (DHEA-S). The variability indices employed were the intra- and inter-individual standard deviation, coefficient of variation, and intra-class correlation coefficient. We found that family caregivers in the music intervention group had significantly greater coefficients of variation for all three biomarker endpoints than those in the control group. Our findings provide evidence that stress biomarkers in family caregivers with functional self-regulation capacities may be more likely to respond to music intervention. However, stress biomarkers in people living with dementia may not be responsive to music intervention, possibly due to their dysfunctional self-regulation capacities. Future stress biomarker studies involving dyads of people living with dementia and family caregivers should consider biomarker variability patterns in determining the effectiveness of behavioral interventions.

    Download full text (pdf)
    fulltext
  • 15.
    Hallberg, Ida
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Reproductive biology.
    Duque Björvang, Richelle
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health.
    Hadziosmanovic, Nermin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Uppsala Clinical Research Center (UCR).
    Koekkoekk, Jacco
    Vrije Univ Amsterdam, Amsterdam Inst Life & Environm, Environm & Hlth, NL-1081 HV Amsterdam, Netherlands..
    Pikki, Anne
    Carl von Linnekliniken, SE-75183 Uppsala, Sweden..
    van Duursen, Majorie
    Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands..
    Lenters, Virissa
    Vrije Univ Amsterdam, Amsterdam Inst Life & Environm, Environm & Hlth, NL-1081 HV Amsterdam, Netherlands.;Univ Utrecht, Univ Med Ctr Utrecht, Julius Ctr Hlth Sci & Primary Care, Univ Weg 100, NL-3584 CG Utrecht, Netherlands..
    Sjunnesson, Ylva
    Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden..
    Holte, Jan
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Reproductive biology. Carl von Linnekliniken, SE-75183 Uppsala, Sweden..
    Berglund, Lars
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Dalarna Univ, Sch Hlth & Welf, S-79131 Falun, Sweden..
    Persson, Sara
    Swedish Univ Agr Sci, Dept Clin Sci, SE-75007 Uppsala, Sweden..
    Olovsson, Matts
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Women's and Children's Health, Reproductive biology. Karolinska Inst, Dept Clin Sci Intervent & Technol, Div Obstet & Gynecol, SE-14186 Stockholm, Sweden..
    Damdimopoulou, Pauliina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Uppsala Clinical Research Center (UCR). Karolinska Univ, Dept Reprod Med, Dept Med, Hosp Huddinge, SE-14186 Stockholm, Sweden..
    Associations between lifestyle factors and levels of per- and polyfluoroalkyl substances (PFASs), phthalates and parabens in follicular fluid in women undergoing fertility treatment2023In: Journal of Exposure Science and Environmental Epidemiology, ISSN 1559-0631, E-ISSN 1559-064X, Vol. 33, p. 699-709Article in journal (Refereed)
    Abstract [en]

    Background: Concerns have been raised whether exposure to endocrine-disrupting chemicals (EDCs) can alter reproductive functions and play a role in the aetiology of infertility in women. With increasing evidence of adverse effects, information on factors associated with exposure is necessary to form firm recommendations aiming at reducing exposure.

    Objective: Our aim was to identify associations between lifestyle factors including the home environment, use of personal care products (PCP), and dietary habits and concentrations of EDCs in ovarian follicular fluid.

    Methods: April-June 2016, 185 women undergoing ovum pick-up for in vitro fertilisation in Sweden were recruited. Correlation analyses were performed between self-reported lifestyle factors and concentration of EDCs analysed in follicular fluid. Habits related to cleaning, PCPs, and diet were assessed together with concentration of six per- and polyfluoroalkyl substances (PFASs) [PFHxS, PFOA, PFOS, PFNA, PFDA and PFUnDA], methyl paraben and eight phthalate metabolites [MECPP, MEHPP, MEOHP, MEHP, cxMinCH, cxMiNP, ohMiNP, MEP, MOHiBP]. Spearman's partial correlations were adjusted for age, parity and BMI.

    Results: Significant associations were discovered between multiple lifestyle factors and concentrations of EDCs in ovarian follicular fluid. After correcting p values for multiple testing, frequent use of perfume was associated with MEP (correlation rho = 0.41 (confidence interval 0.21-0.47), p < 0.001); hens' egg consumption was positively associated with PFOS (rho = 0.30 (0.15-0.43), p = 0.007) and PFUnDA (rho = 0.27 (0.12-0.40), p = 0.036). White fish consumption was positively associated with PFUnDA (rho = 0.34 (0.20-0.47), p < 0.001) and PFDA (rho = 0.27 (0.13-0.41), p = 0.028). More correlations were discovered when considering the raw uncorrected p values. Altogether, our results suggest that multiple lifestyle variables affect chemical contamination of follicular fluid.

    Impact statement: This study shows how lifestyle factors correlate with the level of contamination in the ovary by both persistent and semi-persistent chemicals in women of reproductive age. Subsequently, these data can be used to form recommendations regarding lifestyle to mitigate possible negative health outcomes and fertility problems associated with chemical exposure, and to inform chemical policy decision making. Our study can also help form the basis for the design of larger observational and intervention studies to examine possible effects of lifestyle changes on exposure levels, and to unravel the complex interactions between biological factors, lifestyle and chemical exposures in more detail.

    Download full text (pdf)
    FULLTEXT01
  • 16. Halvorsen, Kjartan
    et al.
    Peng, Wei
    Olsson, Fredrik
    Åberg, Anna Cristina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Högskolan Dalarna.
    Two-step deep-learning identification of heel keypoints from video-recorded gait.2025In: Medical and Biological Engineering and Computing, ISSN 0140-0118, E-ISSN 1741-0444, Vol. 63, no 1, p. 229-237Article in journal (Refereed)
    Abstract [en]

    Accurate and fast extraction of step parameters from video recordings of gait allows for richer information to be obtained from clinical tests such as Timed Up and Go. Current deep-learning methods are promising, but lack in accuracy for many clinical use cases. Extracting step parameters will often depend on extracted landmarks (keypoints) on the feet. We hypothesize that such keypoints can be determined with an accuracy relevant for clinical practice from video recordings by combining an existing general-purpose pose estimation method (OpenPose) with custom convolutional neural networks (convnets) specifically trained to identify keypoints on the heel. The combined method finds keypoints on the posterior and lateral aspects of the heel of the foot in side-view and frontal-view images from which step length and step width can be determined for calibrated cameras. Six different candidate convnets were evaluated, combining three different standard architectures as networks for feature extraction (backbone), and with two different networks for predicting keypoints on the heel (head networks). Using transfer learning, the backbone networks were pre-trained on the ImageNet dataset, and the combined networks (backbone + head) were fine-tuned on data from 184 trials of older, unimpaired adults. The data was recorded at three different locations and consisted of 193 k side-view images and 110 k frontal-view images. We evaluated the six different models using the absolute distance on the floor between predicted keypoints and manually labelled keypoints. For the best-performing convnet, the median error was 0.55 cm and the 75% quartile was below 1.26 cm using data from the side-view camera. The predictions are overall accurate, but show some outliers. The results indicate potential for future clinical use by automating a key step in marker-less gait parameter extraction.

  • 17.
    Kallström, Angelica
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Örebro Univ, Sch Med Sci, Örebro, Sweden..
    Giedraitis, Vilmantas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Franzon, Kristin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Löwenmark, Malin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences.
    Kilander, Lena
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Boström, Gustaf
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.
    Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82-Year-Old Men From the Uppsala Longitudinal Study of Adult Men2024In: International Journal of Geriatric Psychiatry, ISSN 0885-6230, E-ISSN 1099-1166, Vol. 39, no 10, article id e70000Article in journal (Refereed)
    Abstract [en]

    Background: Depression and dementia are known to be associated. The identification of characteristics distinguishing depression prodromal to dementia from other depressive symptoms would be of value for early identification of dementia. The study of risk factors for depressive symptoms prodromal to dementia could improve preventive care and provide clues to the causes of dementia.

    Method: Dementia-free 82-year-old participants were stratified into groups that did (n = 126) and did not (n = 378) subsequently develop dementia. Examinations took place from 2003 to 2005 and follow-up ended 1 January 2015. Their baseline characteristics and depressive symptoms, measured using the 15-item Geriatric Depression Scale (GDS-15), were compared. Multivariate regression analyses were performed for the two groups separately, with the total GDS-15 score as the dependent variable.

    Results: The groups did not differ significantly in answers to any of the GDS-15 questions, or mean +/- SD score, which was 2.4 +/- 2.5 among those who developed dementia and 2.1 +/- 2.3 among those who did not. (p = 0.33). Stroke before the age of 82 years and the inability to use stairs had significant impacts on the GDS-15 scores in both groups. For those who did not develop dementia, age, dependence in activities of daily living, and cancer also had significant impacts. Cancer had opposite associations with depressive symptoms in the two groups.

    Conclusions: No difference was found in depressive symptoms preceding and not preceding dementia using the GDS-15. The results suggest that risk factors for depressive symptoms may differ depending on whether they precede dementia.

    Download full text (pdf)
    fulltext
  • 18.
    Kanis, J. A.
    et al.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia.;Univ Sheffield, Ctr Metab Bone Dis, Sheffield, England..
    Johansson, H.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia.;Univ Gothenburg, Inst Med, Sahlgrenska Osteoporosis Ctr, Gothenburg, Sweden..
    McCloskey, E. , V
    Liu, E.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Akesson, K. E.
    Lund Univ, Dept Clin Sci, Clin & Mol Osteoporosis Res Unit, Lund, Sweden.;Skane Univ Hosp, Dept Orthoped, Malmö, Sweden..
    Anderson, F. A.
    Univ Massachusetts, Med Sch, Ctr Outcomes Res, GLOW Coordinating Ctr, Worcester, MA USA..
    Azagra, R.
    Autonomous Univ Barcelona, Dept Med, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Badia Valles, Barcelona, Spain.;PRECIOSA Fdn invest, Barbera Valles, Barcelona, Spain..
    Bager, C. L.
    Nord Biosci AS, Herlev, Denmark..
    Beaudart, C.
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium.;Maastricht Univ, Dept Hlth Serv Res, Maastricht, Netherlands..
    Bischoff-Ferrari, H. A.
    Univ Zurich Hosp, Dept Aging Med & Aging Res, Zurich, Switzerland.;Univ Zurich, Zurich, Switzerland.;Univ Zurich & City Hosp, Ctr Aging & Mobil, Zurich, Switzerland..
    Biver, E.
    Univ Hosp Geneva, Dept Med, Div Bone Dis, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Bruyere, O.
    Univ Liege, Div Publ Hlth Epidemiol & Hlth Econ, WHO Collaborating Ctr Publ Hlth Aspects Musculosk, Liege, Belgium..
    Cauley, J. A.
    Univ Pittsburgh, Sch Publ Hlth, Dept Epidemiol, Pittsburgh, PA USA..
    Center, J. R.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Chapurlat, R.
    Univ Claude Bernard Lyon1, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Christiansen, C.
    Nord Biosci AS, Herlev, Denmark..
    Cooper, C.
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England.;Univ Oxford, NIHR Oxford Biomed Res Unit, Oxford, England..
    Crandall, C. J.
    Univ Calif Los Angeles, David Geffen Sch Med, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA..
    Cummings, S. R.
    San Francisco Coordinating Ctr, Calif Pacific Med Ctr Res Inst, San Francisco, CA USA..
    da Silva, J. A. P.
    Univ Coimbra, Coimbra Inst Clin & Biomed Res, Fac Med, Coimbra, Portugal.;Ctr Hosp & Univ Coimbra, Dept Rheumatol, Coimbra, Portugal..
    Dawson-Hughes, B.
    Tufts Univ, Jean Mayer US Dept Agr Human Nutr Res Ctr Aging, Bone Metab Lab, Boston, MA USA..
    Diez-Perez, A.
    Autonomous Univ Barcelona, Hosp Mar, Dept Internal Med, Barcelona, Spain.;Autonomous Univ Barcelona, CIBERFES, Barcelona, Spain..
    Dufour, A. B.
    Marcus Inst Aging Res, Hebrew Senior Life, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA..
    Eisman, J. A.
    Garvan Inst Med Res, Skeletal Dis Program, Sydney, NSW, Australia.;Univ New South Wales Sydney, Sch Med & Hlth, St Vincents Clin Sch, Sydney, NSW, Australia.;Univ Notre Dame Australia, Sch Med Sydney, Sydney, NSW, Australia..
    Elders, P. J. M.
    Harvard Med Sch, Boston, MA USA..
    Ferrari, S.
    Univ Hosp Geneva, Dept Med, Div Bone Dis, Geneva, Switzerland.;Univ Geneva, Fac Med, Geneva, Switzerland..
    Fujita, Y.
    Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Locat AMC, Petra JM Elders Dept Gen Practice, Amsterdam, Netherlands..
    Fujiwara, S.
    Kindai Univ, Ctr Med Educ & Clin Training, Fac Med, Osaka, Japan..
    Glueer, C. -c.
    Yasuda Womens Univ, Dept Pharm, Hiroshima, Japan..
    Goldshtein, I.
    Univ Kiel, Univ Med Ctr Schleswig Holstein Kiel, Sect Biomed Imaging, Mol Imaging North Competence Ctr,Dept Radiol & Ne, Kiel, Germany.;Maccabitech Inst Res & Innovat, Maccabi Healthcare Serv, Tel Aviv, Israel..
    Goltzman, D.
    Tel Aviv Univ, Sch Publ Hlth, Dept Epidemiol & Prevent Med, Sackler Fac Med, Tel Aviv, Israel..
    Gudnason, V.
    McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ, Hlth Ctr, Montreal, PQ, Canada.;Iceland Heart Assoc, Kopavogur, Iceland.;Univ Iceland, Reykjavik, Iceland..
    Hall, J.
    Univ Edinburgh, MRC Ctr Reprod Hlth, Edinburgh, Midlothian, Scotland..
    Hans, D.
    Lausanne Univ Hosp CHUV, Bone & Joint Dept, Interdisciplinary Ctr Bone Dis, Lausanne, Switzerland.;Univ Lausanne, Lausanne, Switzerland..
    Hoff, M.
    Norwegian Univ Sci & Technol, Dept Neuromed & Movement Sci, Trondheim, Norway.;St Olavs Hosp, Dept Rheumatol, Trondheim, Norway..
    Hollick, R. J.
    Univ Aberdeen, Epidemiol Grp, Aberdeen Ctr Arthrit & Musculoskeletal Hlth, Aberdeen, Scotland..
    Huisman, M.
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands.;Vrije Univ Amsterdam, Dept Sociol, Amsterdam, Netherlands..
    Iki, M.
    Kindai Univ, Dept Publ Hlth, Fac Med, Osaka, Japan..
    Ish-Shalom, S.
    Elisha Hosp, Endocrine Clin, Haifa, Israel..
    Jones, G.
    Univ Tasmania, Menzies Inst Med Res, Hobart, Tas, Australia..
    Karlsson, M. K.
    Khosla, S.
    Mayo Clin, Coll Med, Robert & Arlene Kogod Ctr Aging, Rochester, MN USA.;Mayo Clin, Coll Med, Div Endocrinol, Rochester, MN USA..
    Kiel, D. P.
    Marcus Inst Aging Res, Hebrew Senior Life, Boston, MA USA.;Beth Israel Deaconess Med Ctr, Dept Med, Boston, MA USA..
    Koh, W. -p.
    Natl Univ Singapore, Yong Loo Lin Sch Med, Healthy Longev Translat Res Programme, Singapore, Singapore.;Agcy Sci Technol & Res STAR, Singapore Inst Clin Sci, Singapore, Singapore..
    Koromani, F.
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands.;Erasmus MC, Dept Radiol & Nucl Med, Rotterdam, Netherlands..
    Kotowicz, M. A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Western Hlth, Dept Med, St Albans, Vic, Australia..
    Kroger, H.
    Kuopio Univ Hosp, Dept Orthoped & Traumatol, Kuopio, Finland.;Univ Eastern Finland, Kuopio Musculoskeletal Res Unit, Kuopio, Finland..
    Kwok, T.
    Chinese Univ Hong Kong, Dept Med & Therapeut, Fac Med, Hong Kong, Peoples R China.;Chinese Univ Hong Kong, Jockey Club Ctr Osteoporosis Care & Control, Fac Med, Hong Kong, Peoples R China..
    Lamy, O.
    Lausanne Univ Hosp, Ctr Bone Dis, Lausanne, Switzerland.;Lausanne Univ Hosp, Serv Internal Med, Lausanne, Switzerland..
    Langhammer, A.
    Norwegian Univ Sci & Technol, HUNT Res Ctr, Dept Publ Hlth & Nursing, Fac Med & Hlth Sci, Trondheim, Norway..
    Larijani, B.
    Univ Tehran Med Sci, Endocrinol & Metab Res Ctr, Endocrinol & Metab Clin Sci Inst, Tehran, Iran..
    Lippuner, K.
    Univ Bern, Univ Hosp Bern, Dept Osteoporosis, Bern, Switzerland..
    Mellstrom, D.
    Univ Gothenburg, Sahlgrenska Acad, Inst Med, Dept Internal Med & Clin Nutr, Gothenburg, Sweden.;Sahlgrenska Univ Hosp Mölndal, Geriatr Med, Mölndal, Sweden..
    Merlijn, T.
    Amsterdam UMC, Amsterdam Publ Hlth Res Inst, Locat AMC, Dept Gen Practice, Amsterdam, Netherlands..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway.;Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sports Res Ctr, Östersund, Sweden..
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    O'Neill, T. W.
    Manchester Univ NHS Fdn Trust, Manchester Acad Hlth Sci Ctr, Natl Inst Hlth Res Manchester Biomed Res Ctr, Manchester, Lancs, England.;Univ Manchester, Ctr Epidemiol Versus Arthrit, Manchester, Lancs, England..
    Obermayer-Pietsch, B.
    Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria.;Ctr Biomarker Res Med, Graz, Austria..
    Ohlsson, C.
    Univ Gothenburg, Sahlgrenska Acad, Inst Med, Sahlgrenska Osteoporosis Ctr,Dept Internal Med &, Gothenburg, Sweden.;Sahlgrens Univ Hosp, Dept Drug Treatment, Region Vastra Gotaland, Gothenburg, Sweden..
    Orwoll, E. S.
    Oregon Hlth & Sci Univ, Dept Med, Portland, OR USA..
    Pasco, J. A.
    Deakin Univ, IMPACT Inst Mental & Phys Hlth & Clin Translat, Geelong, Vic, Australia.;Barwon Hlth, Geelong, Vic, Australia.;Univ Melbourne, Western Hlth, Dept Med, St Albans, Vic, Australia.;Monash Univ, Dept Epidemiol & Prevent Med, Melbourne, Australia..
    Rivadeneira, F.
    Erasmus MC, Dept Internal Med, Rotterdam, Netherlands..
    Schott, A. -M
    Shiroma, E. J.
    Natl Inst Aging, Lab Epidemiol & Populat Sci, Baltimore, MD USA..
    Siggeirsdottir, K.
    McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ, Hlth Ctr, Montreal, PQ, Canada.;Janus Rehabil, Reykjavik, Iceland..
    Simonsick, E. M.
    Natl Inst Aging Intramural Res Program, Translat Gerontol Branch, Baltimore, MD USA..
    Sornay-Rendu, E.
    Univ Lyon, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Sund, R.
    Swart, K. M. A.
    Harvard Med Sch, Boston, MA USA.;PHARMO Inst Drug Outcomes Res, Utrecht, Netherlands..
    Szulc, P.
    Univ Lyon, INSERM UMR 1033, Hop Edouard Herriot, Lyon, France..
    Tamaki, J.
    Osaka Med & Pharmaceut Univ, Dept Hyg & Publ Hlth, Fac Med, Educ Fdn, Osaka, Japan..
    Torgerson, D. J.
    Univ York, Dept Hlth Sci, York Trials Unit, York, N Yorkshire, England..
    van Schoor, N. M.
    Vrije Univ Amsterdam Med Ctr, Amsterdam Publ Hlth Res Inst, Dept Epidemiol & Data Sci, Amsterdam, Netherlands..
    van Staa, T. P.
    Univ Manchester, Sch Hlth Sci, Ctr Hlth Informat, Fac Biol Med & Hlth, Manchester, Lancs, England..
    Vila, J.
    Hosp Mar Med Res Inst, CIBER Epidemiol & Publ Hlth CIBERESP, Stat Support Unit, Barcelona, Spain..
    Wareham, N. J.
    Univ Cambridge, MRC Epidemiol Unit, Cambridge, England..
    Wright, N. C.
    Univ Alabama Birmingham, Dept Epidemiol, Birmingham, AL USA..
    Yoshimura, N.
    Tokyo Univ Hosp, Dept Prevent Med Locomot Organ Disorders, Tokyo, Japan..
    Zillikens, M. C.
    Zwart, M.
    PRECIOSA Fdn invest, Barbera Valles, Barcelona, Spain.;Catalan Inst Hlth, Hlth Ctr Can Gibert Pla, Girona, Spain.;Univ Girona, Dept Med Sci, Girona, Spain.;Inst Univ dInvest Atencio Primaria Jordi Gol, Unitat Suport Recerca Girona, GROIMAP GROICAP Res grp, Girona, Spain..
    Vandenput, L.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Harvey, N. C.
    Univ Southampton, MRC Lifecourse Epidemiol Ctr, Southampton, Hants, England.;Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England.;Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England..
    Lorentzon, M.
    Australian Catholic Univ, Mary McKillop Inst Hlth Res, Melbourne, Australia..
    Leslie, W. D.
    Univ Manitoba, Dept Med, Winnipeg, MB, Canada..
    Previous fracture and subsequent fracture risk: a meta-analysis to update FRAX2023In: Osteoporosis International, ISSN 0937-941X, E-ISSN 1433-2965, Vol. 34, no 12, p. 2027-2045Article in journal (Refereed)
    Abstract [en]

    A large international meta-analysis using primary data from 64 cohorts has quantified the increased risk of fracture associated with a previous history of fracture for future use in FRAX.IntroductionThe aim of this study was to quantify the fracture risk associated with a prior fracture on an international basis and to explore the relationship of this risk with age, sex, time since baseline and bone mineral density (BMD).MethodsWe studied 665,971 men and 1,438,535 women from 64 cohorts in 32 countries followed for a total of 19.5 million person-years. The effect of a prior history of fracture on the risk of any clinical fracture, any osteoporotic fracture, major osteoporotic fracture, and hip fracture alone was examined using an extended Poisson model in each cohort. Covariates examined were age, sex, BMD, and duration of follow-up. The results of the different studies were merged by using the weighted & beta;-coefficients.ResultsA previous fracture history, compared with individuals without a prior fracture, was associated with a significantly increased risk of any clinical fracture (hazard ratio, HR = 1.88; 95% CI = 1.72-2.07). The risk ratio was similar for the outcome of osteoporotic fracture (HR = 1.87; 95% CI = 1.69-2.07), major osteoporotic fracture (HR = 1.83; 95% CI = 1.63-2.06), or for hip fracture (HR = 1.82; 95% CI = 1.62-2.06). There was no significant difference in risk ratio between men and women. Subsequent fracture risk was marginally downward adjusted when account was taken of BMD. Low BMD explained a minority of the risk for any clinical fracture (14%), osteoporotic fracture (17%), and for hip fracture (33%). The risk ratio for all fracture outcomes related to prior fracture decreased significantly with adjustment for age and time since baseline examination.ConclusionA previous history of fracture confers an increased risk of fracture of substantial importance beyond that explained by BMD. The effect is similar in men and women. Its quantitation on an international basis permits the more accurate use of this risk factor in case finding strategies.

  • 19.
    Kepp, Kasper P.
    et al.
    Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA USA..
    Aavitsland, Preben
    Univ Bergen, Pandem Ctr, Bergen, Norway.;Norwegian Inst Publ Hlth, Oslo, Norway..
    Ballin, Marcel
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Reg Stockholm, Ctr Epidemiol & Community Med, Stockholm, Sweden..
    Balloux, Francois
    UCL, UCL Genet Inst, London, England..
    Baral, Stefan
    Johns Hopkins Sch Publ Hlth, Dept Epidemiol, Baltimore, MD USA.;Johns Hopkins Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA.;Johns Hopkins Sch Publ Hlth, Dept Hlth Policy & Management, Baltimore, MD USA..
    Bardosh, Kevin
    Univ Washington, Sch Publ Hlth, Seattle, WA USA.;Univ Edinburgh, Edinburgh Med Sch, Edinburgh, Scotland..
    Bauchner, Howard
    Boston Univ, Dept Pediat, Sch Med, Boston, MA USA..
    Bendavid, Eran
    Stanford Univ, Dept Med Primary Care & Populat Hlth, Sch Med, Stanford, CA USA.;Stanford Univ, Dept Hlth Policy, Sch Med, Stanford, CA USA.;Stanford Univ, Freeman Spogli Inst Int Studies, Stanford, CA USA..
    Bhopal, Raj
    Univ Edinburgh, Usher Inst, Edinburgh, Scotland..
    Blumstein, Daniel T.
    Univ Calif Los Angeles, Inst Environm & Sustainabil, Dept Ecol & Evolutionary Biol, Los Angeles, CA USA..
    Boffetta, Paolo
    Univ Bologna, Dept Med & Surg Sci, Bologna, Italy.;SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY USA..
    Bourgeois, Florence
    Harvard Med Sch, Dept Pediat, Boston, MA USA..
    Brufsky, Adam
    Univ Pittsburgh, Div Hematoloncol, Dept Med, Pittsburgh, PA USA..
    Collignon, Peter J.
    Canberra Hosp, Dept Infect Dis & Microbiol, Garran, ACT, Australia.;Australian Natl Univ, Dept Infect Dis, Med Sch, Acton, ACT, Australia..
    Cripps, Sally
    Univ Technol Sydney, Human Technol Inst, Sydney, NSW, Australia..
    Cristea, Ioana A.
    Univ Padua, Dept Gen Psychol, Padua, Italy..
    Curtis, Nigel
    Univ Melbourne, Dept Paediat, Parkville, Australia.;Murdoch Childrens Res Inst, Infect Dis Res Grp, Parkville, Australia.;Royal Childrens Hosp Melbourne, Infect Dis Unit, Parkville, Australia..
    Djulbegovic, Benjamin
    Med Univ South Carolina, Div Hematol Oncol, Dept Med, Charleston, SC USA..
    Faude, Oliver
    Univ Basel, Dept Sport Exercise & Hlth, Basel, Switzerland..
    Flacco, Maria Elena
    Univ Ferrara, Dept Environm & Prevent Sci, Ferrara, Italy..
    Guyatt, Gordon H.
    McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Fac Hlth Sci, Hamilton, ON, Canada.;McMaster Univ, Dept Med, Fac Hlth Sci, Hamilton, ON, Canada..
    Hajishengallis, George
    Univ Penn, Dept Basic & Translat Sci, Penn Dent Med, Philadelphia, PA USA..
    Hemkens, Lars G.
    Univ Basel, Univ Basel Hosp, Dept Clin Res, Basel, Switzerland..
    Hoffmann, Tammy
    Bond Univ, Inst Evidence Based Healthcare, Fac Hlth Sci & Med, Robina, Qld, Australia..
    Joffe, Ari R.
    Univ Alberta, Dept Pediat, Edmonton, AB, Canada.;Univ Alberta, John Dossetor Hlth Eth Ctr, Edmonton, AB, Canada..
    Klassen, Terry P.
    Univ Manitoba, Childrens Hosp Res Inst Manitoba, Rady Fac Hlth Sci, Dept Pediat & Child Hlth, Winnipeg, MB, Canada..
    Koletsi, Despina
    Univ Zurich, Ctr Dent Med, Clin Orthodont & Pediat Dent, Zurich, Switzerland..
    Kontoyiannis, Dimitrios P.
    Univ Texas MD Anderson Canc Ctr, Div Internal Med, Dept Infect Dis Infect Control & Employee Hlth, Houston, TX USA..
    Kuhl, Ellen
    Stanford Univ, Dept Mech Engn, Stanford, CA USA.;Stanford Univ, Dept Bioengn, Stanford, CA USA..
    La Vecchia, Carlo
    Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy..
    Lallukka, Tea
    Univ Helsinki, Dept Publ Hlth, Helsinki, Finland..
    Lambris, John
    Univ Penn, Dept Pathol & Lab Med, Perelman Sch Med, Philadelphia, PA USA..
    Levitt, Michael
    Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA USA..
    Makridakis, Spyros
    Univ Nicosia, Inst Future IFF, Nicosia, Cyprus..
    Maltezou, Helena C.
    Natl Publ Hlth Org, Directorate Res Studies & Documentat, Athens, Greece..
    Manzoli, Lamberto
    Marusic, Ana
    Univ Split, Sch Med, Dept Res Biomed & Hlth, Split, Croatia.;Univ Split, Sch Med, Ctr Evidence Based Med, Split, Croatia..
    Mavragani, Clio
    Natl & Kapodistrian Univ Athens, Med Sch, Dept Physiol, Athens, Greece..
    Moher, David
    Ottawa Hosp Res Inst, Ctr Journalol, Clin Epidemiol Program, Ottawa, ON, Canada.;Univ Ottawa, Sch Epidemiol & Publ Hlth, Fac Med, Ottawa, ON, Canada..
    Mol, Ben W.
    Monash Univ, Dept Obstet & Gynaecol, Clayton, Australia..
    Muka, Taulant
    Epistudia, Bern, Switzerland..
    Naudet, Florian
    Univ Rennes, Res Inst Environm & Occupat Hlth, IRSET, UMR S INSERM 1085, Rennes, France.;Inst Univ France, Paris, France.;Rennes Univ Hosp, Clin Investigat Ctr, INSERM CIC 1414, Rennes, France.;Rennes Univ Hosp, Psychiat Dept, Rennes, France..
    Noble, Paul W.
    Cedars Sinai Med Ctr, Dept Med, Womens Guild Lung Inst, Los Angeles, CA USA..
    Nordstrom, Anna
    Umeå Univ, Dept Publ Hlth & Clin Med, Umeå, Sweden.;UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway.;Mid Sweden Univ, Dept Hlth Sci, Swedish Winter Sport Res Ctr, Östersund, Sweden..
    Nordstrom, Peter
    Uppsala Univ, Dept Publ Hlth & Caring Sci, Clin Geriatr, Uppsala, Sweden..
    Pandis, Nikolaos
    Univ Bern, Dent Sch, Dept Orthodont & Dentofacial Orthoped, Med Fac, Bern, Switzerland..
    Papatheodorou, Stefania
    Rutgers Sch Publ Hlth, Dept Biostat & Epidemiol, Piscataway, NJ USA.;Harvard TH Chan Sch Publ Hlth, Dept Epidemiol, Boston, MA USA..
    Patel, Chirag J.
    Harvard Med Sch, Dept Biomed Informat, Boston, MA USA..
    Petersen, Irene
    UCL, Dept Primary Care & Populat Hlth, London, England..
    Pilz, Stefan
    Med Univ Graz, Div Endocrinol & Diabetol, Dept Internal Med, Graz, Austria..
    Plesnila, Nikolaus
    Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res ISD, Munich, Germany.;Munich Cluster Syst Neurol Synergy, Munich, Germany..
    Ponsonby, Anne-Louise
    Florey Inst Neurosci & Mental Hlth, Melbourne, Australia.;Royal Childrens Hosp, Murdoch Childrens Res Inst, Melbourne, Australia.;Univ Melbourne, Sch Populat & Global Hlth, Ctr Epidemiol & Biostat, Melbourne, Australia..
    Rivas, Manuel A.
    Stanford Univ, Dept Biomed Data Sci, Sch Med, Stanford, CA USA..
    Saltelli, Andrea B. U.
    UPF Barcelona Sch Management, Barcelona, Spain.;Univ Bergen, Ctr Study Sci & Humanities, Bergen, Norway..
    Schabus, Manuel
    Univ Salzburg, Dept Psychol, Salzburg, Austria..
    Schippers, Michaela C.
    Erasmus Univ, Dept Org & Personnel Management, Rotterdam, Netherlands..
    Schunemann, Holger
    McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Fac Hlth Sci, Hamilton, ON, Canada..
    Solmi, Marco
    Univ Ottawa, Dept Psychiat, Ottawa, ON, Canada.;Charit Univ Med, Dept Child & Adolescent Psychiat, Berlin, Germany..
    Stang, Andreas
    Univ Hosp Essen, Inst Med Informat Biometry & Epidemiol, Essen, Germany..
    Streeck, Hendrik
    Univ Bonn, Inst Virol, Fac Med, Bonn, Germany..
    Sturmberg, Joachim P.
    Univ Newcastle, Coll Hlth Med & Wellbeing, Holgate, NSW, Australia.;Int Soc Syst & Complex Sci Hlth, Waitsfield, VT USA..
    Thabane, Lehana
    McMaster Univ, Dept Hlth Res Methods Evidence & Impact, Fac Hlth Sci, Hamilton, ON, Canada..
    Thombs, Brett D.
    Jewish Gen Hosp, Lady Davis Inst Med Res, Montreal, PQ, Canada.;McGill Univ, Dept Psychiat, Montreal, PQ, Canada.;McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.;McGill Univ, Dept Med, Montreal, PQ, Canada.;McGill Univ, Biomed Eth Unit, Montreal, PQ, Canada.;McGill Univ, Dept Psychol, Montreal, PQ, Canada..
    Tsakris, Athanasios
    Univ Athens, Med Sch, Dept Microbiol, Athens, Greece..
    Wood, Simon N.
    Univ Edinburgh, Sch Math, Chair Computat Stat, Edinburgh, Scotland..
    Ioannidis, John P. A.
    Stanford Univ, Meta Res Innovat Ctr Stanford, Stanford, CA USA.;Stanford Univ, Dept Med, Sch Med, Stanford Prevent Res Ctr, 1265 Welch Rd,Med Sch Off Bldg,Room X306, Stanford, CA 94305 USA.;Stanford Univ, Dept Epidemiol & Populat Hlth, Sch Med, Stanford, CA USA.;Stanford Univ, Dept Stat, Sch Human & Sci, Stanford, CA USA..
    Panel stacking is a threat to consensus statement validity2024In: Journal of Clinical Epidemiology, ISSN 0895-4356, E-ISSN 1878-5921, Vol. 173Article in journal (Other academic)
    Abstract [en]

    Consensus statements can be very influential in medicine and public health. Some of these statements use systematic evidence synthesis but others fail on this front. Many consensus statements use panels of experts to deduce perceived consensus through Delphi processes. We argue that stacking of panel members toward one particular position or narrative is a major threat, especially in absence of systematic evidence review. Stacking may involve financial conflicts of interest, but nonfinancial conflicts of strong advocacy can also cause major bias. Given their emerging importance, we describe here how such consensus statements may be misleading, by analyzing in depth a recent high-impact Delphi consensus statement on COVID-19 recommendations as a case example. We demonstrate that many of the selected panel members and at least 35% of the core panel members had advocated toward COVID-19 elimination (Zero-COVID) during the pandemic and were leading members of aggressive advocacy groups. These advocacy conflicts were not declared in the Delphi consensus publication, with rare exceptions. Therefore, we propose that consensus statements should always require rigorous evidence synthesis and maximal transparency on potential biases toward advocacy or lobbyist groups to be valid. While advocacy can have many important functions, its biased impact on consensus panels should be carefully avoided. (c) 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.

  • 20. Le Borgne, Julie
    et al.
    Gomez, Lissette
    Heikkinen, Sami
    Amin, Najaf
    Ahmad, Shahzad
    Choi, Seung Hoan
    Bis, Joshua
    Grenier-Boley, Benjamin
    Rodriguez, Omar Garcia
    Kleineidam, Luca
    Young, Juan
    Tripathi, Kumar Parijat
    Wang, Lily
    Varma, Achintya
    Campos-Martin, Rafael
    van der Lee, Sven
    Damotte, Vincent
    de Rojas, Itziar
    Palmal, Sagnik
    Lipton, Richard
    Reiman, Eric
    McKee, Ann
    De Jager, Philip
    Bush, William
    Small, Scott
    Levey, Allan
    Saykin, Andrew
    Foroud, Tatiana
    Albert, Marilyn
    Hyman, Bradley
    Petersen, Ronald
    Younkin, Steven
    Sano, Mary
    Wisniewski, Thomas
    Vassar, Robert
    Schneider, Julie
    Henderson, Victor
    Roberson, Erik
    DeCarli, Charles
    LaFerla, Frank
    Brewer, James
    Swerdlow, Russell
    Van Eldik, Linda
    Hamilton-Nelson, Kara
    Paulson, Henry
    Naj, Adam
    Lopez, Oscar
    Chui, Helena
    Crane, Paul
    Grabowski, Thomas
    Kukull, Walter
    Asthana, Sanjay
    Craft, Suzanne
    Strittmatter, Stephen
    Cruchaga, Carlos
    Leverenz, James
    Goate, Alison
    Kamboh, M Ilyas
    George-Hyslop, Peter St
    Valladares, Otto
    Kuzma, Amanda
    Cantwell, Laura
    Riemenschneider, Matthias
    Morris, John
    Slifer, Susan
    Dalmasso, Carolina
    Castillo, Atahualpa
    Küçükali, Fahri
    Peters, Oliver
    Schneider, Anja
    Dichgans, Martin
    Rujescu, Dan
    Scherbaum, Norbert
    Deckert, Jürgen
    Riedel-Heller, Steffi
    Hausner, Lucrezia
    Molina-Porcel, Laura
    Düzel, Emrah
    Grimmer, Timo
    Wiltfang, Jens
    Heilmann-Heimbach, Stefanie
    Moebus, Susanne
    Tegos, Thomas
    Scarmeas, Nikolaos
    Dols-Icardo, Oriol
    Moreno, Fermin
    Pérez-Tur, Jordi
    Bullido, María J
    Pastor, Pau
    Sánchez-Valle, Raquel
    Álvarez, Victoria
    Boada, Mercè
    García-González, Pablo
    Puerta, Raquel
    Mir, Pablo
    Real, Luis M
    Piñol-Ripoll, Gerard
    García-Alberca, Jose María
    Royo, Jose Luís
    Rodriguez-Rodriguez, Eloy
    Soininen, Hilkka
    de Mendonça, Alexandre
    Mehrabian, Shima
    Traykov, Latchezar
    Hort, Jakub
    Vyhnalek, Martin
    Thomassen, Jesper Qvist
    Pijnenburg, Yolande A L
    Holstege, Henne
    van Swieten, John
    Ramakers, Inez
    Verhey, Frans
    Scheltens, Philip
    Graff, Caroline
    Papenberg, Goran
    Giedraitis, Vilmantas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Geriatrics. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Boland, Anne
    Deleuze, Jean-François
    Nicolas, Gael
    Dufouil, Carole
    Pasquier, Florence
    Hanon, Olivier
    Debette, Stéphanie
    Grünblatt, Edna
    Popp, Julius
    Ghidoni, Roberta
    Galimberti, Daniela
    Arosio, Beatrice
    Mecocci, Patrizia
    Solfrizzi, Vincenzo
    Parnetti, Lucilla
    Squassina, Alessio
    Tremolizzo, Lucio
    Borroni, Barbara
    Nacmias, Benedetta
    Spallazzi, Marco
    Seripa, Davide
    Rainero, Innocenzo
    Daniele, Antonio
    Bossù, Paola
    Masullo, Carlo
    Rossi, Giacomina
    Jessen, Frank
    Fernandez, Victoria
    Kehoe, Patrick Gavin
    Frikke-Schmidt, Ruth
    Tsolaki, Magda
    Sánchez-Juan, Pascual
    Sleegers, Kristel
    Ingelsson, Martin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Geriatrics. Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Molecular Geriatrics.
    Haines, Jonathan
    Farrer, Lindsay
    Mayeux, Richard
    Wang, Li-San
    Sims, Rebecca
    DeStefano, Anita
    Schellenberg, Gerard D
    Seshadri, Sudha
    Amouyel, Philippe
    Williams, Julie
    van der Flier, Wiesje
    Ramirez, Alfredo
    Pericak-Vance, Margaret
    Andreassen, Ole A
    Van Duijn, Cornelia
    Hiltunen, Mikko
    Ruiz, Agustín
    Dupuis, Josée
    Martin, Eden
    Lambert, Jean-Charles
    Kunkle, Brian
    Bellenguez, Céline
    X-chromosome-wide association study for Alzheimer's disease.2024In: Molecular Psychiatry, ISSN 1359-4184, E-ISSN 1476-5578Article in journal (Refereed)
    Abstract [en]

    Due to methodological reasons, the X-chromosome has not been featured in the major genome-wide association studies on Alzheimer's Disease (AD). To address this and better characterize the genetic landscape of AD, we performed an in-depth X-Chromosome-Wide Association Study (XWAS) in 115,841 AD cases or AD proxy cases, including 52,214 clinically-diagnosed AD cases, and 613,671 controls. We considered three approaches to account for the different X-chromosome inactivation (XCI) states in females, i.e. random XCI, skewed XCI, and escape XCI. We did not detect any genome-wide significant signals (P ≤ 5 × 10-8) but identified seven X-chromosome-wide significant loci (P ≤ 1.6 × 10-6). The index variants were common for the Xp22.32, FRMPD4, DMD and Xq25 loci, and rare for the WNK3, PJA1, and DACH2 loci. Overall, this well-powered XWAS found no genetic risk factors for AD on the non-pseudoautosomal region of the X-chromosome, but it identified suggestive signals warranting further investigations.

  • 21.
    Le Guen, Yann
    et al.
    Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA.;Inst Cerveau Paris Brain Inst, F-75013 Paris, France..
    Luo, Guo
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Ambati, Aditya
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA.;IRCCS Fdn Policlin A Univ Gemelli, Neurol Unit, I-00168 Rome, Italy.;Ludwig Maximilian Univ Munich, Univ Hosp, Inst Stroke & Dementia Res, D-81377 Munich, Germany..
    Damotte, Vincent
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    Jansen, Iris
    Vrije Univ Amsterdam, Amsterdam UMC, Alzheimer Ctr Amsterdam, Amsterdam Neurosci,Dept Neurol, NL-1081 HV Amsterdam, Netherlands.;Vrije Univ, Ctr Neurogen & Cognit Res, Dept Complex Trait Genet, Amsterdam Neurosci, NL-1081 HV Amsterdam, Netherlands..
    Yu, Eric
    Neuro Montreal Neurol Inst Hosp, Montreal, PQ H3A 2B4, Canada.;McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada.;McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada..
    Nicolas, Aude
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    de Rojasj, Itziar
    Univ Int Catalunya, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona 08029, Spain.;Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain..
    Leal, Thiago Peixoto
    Cleveland Clin, Lerner Res Inst, Gen Med, Cleveland, OH 44196 USA..
    Miyashita, Akinori
    Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata 950218, Japan..
    Bellenguez, Celine
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    Lian, Michelle Mulan
    Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Singapore 308232, Singapore.;ASTAR, Genome Inst Singapore, Lab Neurogenet, Singapore 138672, Singapore..
    Parveen, Kayenat
    Univ Cologne, Univ Hosp Cologne, Div Neurogenet & Mol Psychiat, Dept Psychiat & Psychotherapy, D-50937 Cologne, Germany.;Univ Hosp Bonn, Fac Med, Dept Neurodegenerat Dis & Geriatr Psychiat, D-53127 Bonn, Germany..
    Morizono, Takashi
    Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Res Inst, Obu 4748511, Japan..
    Park, Hyeonseul
    Chosun Univ, Dept Biomed Sci, Gwangju 61452, South Korea..
    Grenier-Boley, Benjamin
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    Naito, Tatsuhiko
    Osaka Univ, Grad Sch Med, Dept Stat Genet, Suita, Osaka 5650871, Japan.;Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1920982, Japan..
    Kucukali, Fahri
    VIB, VIB Ctr Mol Neurol, Complex Genet Alzheimers Dis Grp, B-2610 Antwerp, Belgium.;Inst Born Bunge, Lab Neurogenet, B-2610 Antwerp, Belgium.;Univ Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium..
    Talyansky, Seth D.
    Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA..
    Yogeshwar, Selina Maria
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA.;Charite, Dept Neurol, D-10117 Berlin, Germany.;Charite Univ Med Berlin, Ctr Neurosci Berlin, D-10117 Berlin, Germany..
    Sempere, Vicente
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Satake, Wataru
    Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1920982, Japan..
    Alvarez, Victoria
    Hosp Univ Cent Asturias, Lab Genet, Oviedo 33011, Spain.;Sanitaria Principado Asturias, Inst Invest, Oviedo 33011, Spain..
    Arosio, Beatrice
    Univ Milan, Dept Clin Sci & Community Hlth, I-20122 Milan, Italy..
    Belloy, Michael E.
    Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA..
    Benussi, Luisa
    IRCCS Ist Ctr San Giovanni Dio Fatebenefratell, Mol Markers Lab, I-25125 Brescia, Italy..
    Boland, Anne
    Univ Paris Saclay, CEA, Ctr Natl Rech Genom Humaine, F-91057 Evry, France..
    Borroni, Barbara
    Univ Brescia, Neurol Unit, Ctr Neurodegenerat Disorders, Dept Clin & Expt Sci, I-25123 Brescia, Italy..
    Bullido, Maria J.
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Univ Autonoma Madrid, Ctr Biol Mol Severo Ochoa UAM CSIC, Madrid 28049, Spain.;Inst Invest Sanit Hosp La Paz IdIPaz, Madrid 48903, Spain..
    Caffarra, Paolo
    Univ Parma, Unit Neurol, I-43121 Parma, Italy.;AOU, I-43121 Parma, Italy..
    Clarimon, Jordi
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Univ Autonoma Barcelona, Hosp Santa Creu & Sant Pau, Dept Neurol Sant Pau 2B, Barcelona 08193, Spain..
    Daniele, Antonio
    Univ Cattolica Sacro Cuore, Dept Neurosci, I-00168 Rome, Italy.;IRCCS Fdn Policlin A Univ Gemelli, Neurol Unit, I-00168 Rome, Italy..
    Darling, Daniel
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Debette, Stephanie
    Univ Bordeaux, INSERM, Bordeaux Populat Hlth Res Ctr, F-33000 Bordeaux, France.;Bordeaux Univ Hosp, Dept Neurol, F-33400 Bordeaux, France..
    Deleuze, Jean-Francois
    Univ Paris Saclay, CEA, Ctr Natl Rech Genom Humaine, F-91057 Evry, France..
    Dichgans, Martin
    Ludwig Maximilian Univ Munich, Univ Hosp, Inst Stroke & Dementia Res, D-81377 Munich, Germany.;German Ctr Neurodegenerat Dis, D-37075 Munich, Germany.;Munich Cluster Syst Neurol, D-81377 Munich, Germany..
    Dufouil, Carole
    Univ Bordeaux, Bordeaux Populat Hlth Res Ctr, Inserm, ISPED,UMR 1219,CIC 1401 EC, F-33405 Bordeaux, France.;CHU Bordeaux, Pole St Publ, F-33400 Bordeaux, France..
    During, Emmanuel
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Duzel, Emrah
    German Ctr Neurodegenerat Dis, D-39120 Magdeburg, Germany.;Otto Von Guericke Univ, Inst Cognit Neurol & Dementia Res, D-39106 Magdeburg, Germany..
    Galimberti, Daniela
    Osped Policlin, Fdn IRCCS Ca Granda, Neurodegenerat Dis Unit, I-20122 Milan, Italy.;Univ Milan, Dept Biomed Surg & Dent Sci, I-20122 Milan, Italy..
    Garcia-Ribas, Guillermo
    Hosp Univ Ramon & Cajal, IRYCIS, Madrid 28034, Spain..
    Maria Garcia-Alberca, Jose
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Hosp Univ Ramon & Cajal, IRYCIS, Madrid 28034, Spain.;Alzheimer Res Ctr & Memory Clin, Andalusian Inst Neurosci, Malaga 29012, Spain..
    Garcia-Gonzalez, Pablo
    Univ Int Catalunya, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona 08029, Spain..
    Giedraitis, Vilmantas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Goldhardt, Oliver
    Tech Univ Munich, Klinikum Recs Isar, Sch Med, Dept Psychiat & Psychotherapy, D-80333 Munich, Germany..
    Graff, Caroline
    Karolinska Univ Hosp Solna, Theme Aging, Unit Hereditary Dementias, S-17164 Stockholm, Sweden..
    Grunblatt, Edna
    Univ Zurich, Univ Hosp Psychiat Zurich, Dept Child & Adolescent Psychiat & Psych, CH-8032 Zurich, Switzerland.;Univ Zurich, Neurosci Ctr Zurich, CH-8057 Zurich, Switzerland.;Swiss Fed Inst Technol, CH-8057 Zurich, Switzerland.;Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland..
    Hanon, Olivier
    Univ Paris, Hop Broca, APHP, EA 4468, F-75013 Paris, France..
    Hausner, Lucrezia
    Heidelberg Univ, Fac Mannheim, Cent Inst Mental Hlth Mannheim, Dept Geriatr Psychiat, D-68159 Heidelberg 68159, Germany..
    Heilmann-Heimbach, Stefanie
    Univ Bonn, Sch Med, Inst Human Genet, D-53127 Bonn, Germany.;Univ Hosp Bonn, D-53127 Bonn, Germany..
    Holstege, Henne
    Vrije Univ Amsterdam, Amsterdam UMC, Alzheimer Ctr Amsterdam, Amsterdam Neurosci,Dept Neurol, NL-1081 HV Amsterdam, Netherlands..
    Hort, Jakub
    Charles Univ Prague, Memory Clin, Dept Neurol, Fac Med 2, CZ-15006 Prague, Czech Republic.;Motol Univ Hosp, CZ-15006 Prague, Czech Republic.;St Annes Univ Hosp, Int Clin Res Ctr, CZ-65691 Brno, Czech Republic..
    Jung, Yoo Jin
    Stanford Univ, Sch Med, Stanford Neurosci Interdept Program, Stanford, CA 94305 USA..
    Jurgen, Deckert
    Univ Hosp Wurzburg, Ctr Mental Hlth, Dept Psychiat Psychosomat & Psychotherapy, D-97080 Wurzburg, Germany..
    Kern, Silke
    Univ Gothenburg, Ctr Ageing & Hlth AGECAP, Sahlgrenska Acad,Dept Psychiat & Neurochem, Inst Neurosci & Physiol,Neuropsychiatr Epidemiol, S-40530 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Psychiat Cognit & Old Age Psychiat Clin, Reg Vastra Gotaland, S-41345 Gothenburg, Sweden..
    Kuulasmaa, Teemu
    Univ Eastern Finland, Inst Biomed, Joensuu 80101, Finland..
    Lee, Kun Ho
    Chosun Univ, Dept Biomed Sci, Gwangju 61452, South Korea.;Chosun Univ, Dept Integrat Biol Sci, Gwangju 61452, South Korea.;Chosun Univ, Cohort Res Ctr, Gwangju Alzheimers & Related Dementias, Gwangju 61452, South Korea.;Korea Brain Res Inst, Daegu 41062, South Korea.;Neurozen Inc, Seoul 06236, South Korea..
    Lin, Ling
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Masullo, Carlo
    Univ Cattolica Sacro Cuore, Inst Neurol, I-20123 Rome, Italy..
    Mecocci, Patrizia
    Univ Perugia, Inst Gerontol & Geriatr, Dept Med & Surg, I-06123 Perugia, Italy..
    Mehrabian, Shima
    UH Alexandrovska Med Univ, Clin Neurol, Sofia 1431, Bulgaria..
    de Mendonca, Alexandre
    Univ Lisbon, Fac Med, P-1649028 Lisbon, Portugal..
    Boada, Merce
    Univ Int Catalunya, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona 08029, Spain.;Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain..
    Mir, Pablo
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Univ Seville, Hosp Univ Virgen Rocio, CSIC, Inst Biomed Sevilla,Serv Neurol Neurofisiol,Unida, Seville 41013, Spain..
    Moebus, Susanne
    Univ Duisburg Essen, Univ Hosp, Inst Urban Publ Hlth, D-45147 Essen, Germany..
    Moreno, Fermin
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Hosp Univ Donostia, Dept Neurol, San Sebastian 20014, Spain.;Inst Biodonostia, Neurosci Area, San Sebastian 20014, Spain..
    Nacmias, Benedetta
    Univ Florence, Drug Res & Child Hlth, Dept Neurosci Psychol, I-50121 Florence, Italy.;IRCCS Fdn Don Carlo Gnocchi, I-20162 Florence, Italy..
    Nicolas, Gael
    Normandie Univ, UNIROUEN, Inserm U1245, Dept Genet, Rouen, France.;Normandie Univ, UNIROUEN, Inserm U1245, CNR MAJ, F-76000 Rouen, France..
    Niida, Shumpei
    Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Res Inst, Obu 4748511, Japan..
    Nordestgaard, Borge G.
    Univ Copenhagen, Hosp Herlev Gentofte, Dept Clin Biochem, DK-2730 Copenhagen, Denmark..
    Papenberg, Goran
    Karolinska Inst, Aging Res Ctr, Dept Neurobiol Care Sci & Soc, S-17177 Stockholm, Sweden.;Stockholm Univ, S-17177 Stockholm, Sweden..
    Papma, Janne
    Erasmus Univ, Med Ctr, Alzheimer Ctr, Erasmus MC,Dept Neurol, NL-3000 Rotterdam, Netherlands..
    Parnetti, Lucilla
    Univ Perugia, Neurol Sect, Lab Clin Neurochem, Ctr Memory Disturbances, I-06123 Perugia, Italy..
    Pasquier, Florence
    Univ Lille, Inserm 1172, CHU Clin, F-59000 Lille, France.;Res Memory Res Ctr Distalz, F-59000 Lille, France..
    Pastor, Pau
    Fundacio Docencia & Rec MutuaTerrassa, Barcelona 08221, Spain.;Fundacio Docencia & Rec MutuaTerrassa, Barcelona 08221, Spain..
    Peters, Oliver
    Hosp Univ Mutua Terrassa, Dept Neurol, Memory Disorders Unit, Barcelona 08221, Spain.;German Ctr Neurodegenerat Dis DZNE, D-37075 Berlin, Germany..
    Pijnenburg, Yolande A. L.
    Vrije Univ Amsterdam, Amsterdam UMC, Alzheimer Ctr Amsterdam, Amsterdam Neurosci,Dept Neurol, NL-1081 HV Amsterdam, Netherlands..
    Pinol-Ripoll, Gerard
    Free Univ Berlin, D-12203 Berlin, Germany.;Humbold Univ Berlin, D-12203 Berlin, Germany.;Berlin Inst Hlth, Inst Psychiat & Psychotherapy, D-12203 Berlin, Germany.;Hosp Univ Santa Maria Lleida, Unitat Trastorns Cognitius, Lleida 25198, Spain..
    Popp, Julius
    Inst Rec Biomed Lleida, Lleida 25198, Spain.;Univ Lausanne Hosp, Dept Psychiat Old Age Psychiat, CH-1005 Lausanne, Switzerland.;Univ Hosp Psychiat Zurich, Dept Geriatr Psychiat, CH-8032 Zurich, Switzerland.;Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England..
    Porcel, Laura Molina
    Univ Zurich, Inst Regenerat Med, CH-8952 Zurich, Switzerland.;Neurol Tissue Bank Biobanc Hosp Clin, Inst Invest Biomed August Pi i Sunyer, Barcelona 08036, Spain..
    Jordi Perez-Tur, Raquel Puertaj
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Hosp Clin Barcelona, Alzheimers Dis & Other Cognit Disorders Unit, Dept Neurol, Barcelona 08036, Spain.;Consejo Super Invest Cient Valencia, Inst Biomed Valencia, Unitat Genet Mol, Valencia 46010, Spain.;Inst Invest Sanit La Fe, Unidad Mixta Neurol Genet, Valencia 46026, Spain..
    Rainero, Innocenzo
    Univ Torino, Dept Neurosci Rita Levi Montalcini, I-10126 Turin, Italy..
    Ramakers, Inez
    Maastricht Univ, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, NL-6229GS Maastricht, Netherlands..
    Real, Luis M.
    Hosp Univ Valme, Unidad Clin Enfermedades Infecc & Microbiol, Seville 41014, Spain.;Univ Malaga, Fac Med, Dept Especialidades Quirurg Bioquim & Inmunol, Malaga 29010, Spain..
    Riedel-Heller, Steffi
    Univ Leipzig, Inst Social Med Occupat Hlth & Publ Hlt, D-04109 Leipzig, Germany.;Sahlgrens Acad, Ctr Ageing & Hlth AGECAP, Inst Neurosci & Physiol, Neuropsychiatr Epidemiol Unit,Dept Psychiat & Neu, S-43141 Gothenburg, Sweden.;Univ Gothenburg, S-43141 Gothenburg, Sweden..
    Rodriguez-Rodriguez, Eloy
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Univ Cantabria, Marques Valdecilla Univ Hosp, Neurol Serv, Santander 39011, Spain.;IDIVAL, Santander 39011, Spain..
    Ross, Owen A.
    CHU Rouen, F-76000 Rouen, France.;Mayo Clin Florida, Dept Neurosci, Jacksonville, FL 32224 USA.;Mayo Clinic, Dept Clin Gen, Jacksonville, FL 32224 USA.;Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany..
    Royo, Jose Luis
    Univ Copenhagen, Dept Clin Med, DK-1172 Copenhagen, Denmark.;Univ Malaga, Fac Med, Dept Especialidades Quirurg Bioquim & Immunol, Malaga 29010, Spain..
    Rujescu, Dan
    Martin Luther Univ Halle Wittenberg, Univ Clin, D-06120 Halle, Germany.;Outpatient Clin Psychiat Psychotherapy & Psychoso, D-06120 Halle, Germany..
    Scarmeas, Nikolaos
    Columbia Univ, Taub Inst Res, Alzheimers Dis & Aging Brain, Gertrude H Sergievsky Ctr, New York, NY 10032 USA.;Natl & Kapodistrian Univ Athens, Sch Med, Aiginit Hosp, Dept Neurol 1, Athens 10679, Greece.;Sahlgrens Univ Hosp, Clin Neurochem Lab, SE-43180 Mölndal, Sweden.;UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England.;Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China..
    Scheltens, Philip
    Vrije Univ Amsterdam, Amsterdam UMC, Alzheimer Ctr Amsterdam, Amsterdam Neurosci,Dept Neurol, NL-1081 HV Amsterdam, Netherlands..
    Scherbaum, Norbert
    Univ Duisburg Essen, LVR Hosp Essen, Fac Med, Dept Psychiat & Psychotherapy, D-45147 Essen, Germany.;Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF14 4XN, Wales..
    Schneider, Anja
    German Ctr Neurodegenerat Dis, Deutsch Zentrum Neurodegenerat Erkrankungen, D-37075 Gottingen, Germany.;Univ Hosp Bonn, Dept Neurodegenerat Dis & Geriatr Psychiat, D-53127 Bonn, Germany.;Univ Cologne, Dept Psychiat & Psychotherapy, Fac Med, D-50937 Cologne, Germany..
    Seripa, Davide
    Lab Adv Hematol Diagnost, Dept Hematol & Stem Cell Transplant, I-73100 Lecce, Italy..
    Skoog, Ingmar
    Univ Gothenburg, Ctr Ageing & Hlth AGECAP, Sahlgrenska Acad,Dept Psychiat & Neurochem, Inst Neurosci & Physiol,Neuropsychiatr Epidemiol, S-40530 Gothenburg, Sweden.;Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem,Neuropsychiatr Epidemio, S-40530 Gothenburg, Sweden.;Univ Cologne, Dept Psychiat & Psychotherapy, Fac Med, D-50937 Cologne, Germany.;Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany..
    Solfrizzi, Vincenzo
    Charite Univ Med Berlin, D-12203 Berlin, Germany.;Univ Bari A Moro, Geriatr Med & Memory Unit, Dept Med, I-70121 Bari, Italy..
    Spalletta, Gianfranco
    IRCCS Santa Lucia Fdn, Lab Neuropsychiat, I-00179 Rome, Italy.;Univ Bristol, Bristol Med Sch, Translat Hlth Sci Bristol, Bristol, Avon, England.;Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT Ctr, N-0450 Oslo, Norway..
    Squassina, Alessio
    Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA.;Univ Oslo, Inst Clin Med, Oslo, Norway..
    van Swieten, John
    Univ Cagliari, Dept Biomed Sci, I-09124 Cagliari, Italy.;Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England..
    Sanchez-Valle, Raquel
    ErasmusMC, Dept Neurol, NL-3000 CA Rotterdam, Netherlands.;Alzheimers Ctr Reina Sofia, CIEN Fdn, Madrid, Spain..
    Tan, Eng-King
    Univ Barcelona, Hosp Clin Barcelona, Inst Invest Biomed August Pi & Sunyer, Alzheimers Dis & Other Cognit Disorders Unit,Serv, Barcelona 08036, Spain.;Singapore Gen Hosp, Natl Neurosci Inst, Dept Neurol, Singapore 308433, Singapore.;Duke Natl Univ Singapore, Med Sch, Singapore 169857, Singapore..
    Tegos, Thomas
    Aristotle Univ Thessaloniki, Sch Med, Dept Neurol 1, Thessaloniki 54124, Greece..
    Teunissen, Charlotte
    Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Neurosci, Neurochem Lab,Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands..
    Thomassen, Jesper Qvist
    Copenhagen Univ Hosp, Rigshospitalet, Dept Clin Biochem, DK-2100 Copenhagen, Denmark..
    Tremolizzo, Lucio
    San Gerardo Hosp, Neurol, I-20900 Monza, Italy.;Univ Milano Bicocca, I-20900 Monza, Italy..
    Vyhnalek, Martin
    Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, NL-1081 HV Amsterdam, Netherlands.;Charles Univ Prague, Memory Clin, Dept Neurol, Fac Med 2, CZ-15006 Prague, Czech Republic.;Motol Univ Hosp, CZ-15006 Prague, Czech Republic..
    Verhey, Frans
    Maastricht Univ, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, NL-6229GS Maastricht, Netherlands..
    Waern, Margda
    Sahlgrens Acad, Ctr Ageing & Hlth AGECAP, Inst Neurosci & Physiol, Neuropsychiatr Epidemiol Unit,Dept Psychiat & Neu, S-43141 Gothenburg, Sweden.;Univ Gothenburg, S-43141 Gothenburg, Sweden.;Sahlgrens Univ Hosp, Psychosis Clin, Reg Vastra Gotaland, S-41345 Gothenburg, Sweden..
    Wiltfang, Jens
    Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany.;German Ctr Neurodegenerat Dis, Deutsch Zentrum Neurodegenerat Erkrankungen, D-37075 Gottingen, Germany.;Univ Aveiro, Inst Biomed, Neurosci & Signaling Grp, Dept Med Sci, P-3810193 Aveiro, Portugal..
    Zhangc, Jing
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Zetterberg, Henrik
    Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43141 Mölndal, Sweden.;Sahlgrens Univ Hosp, Clin Neurochem Lab, SE-43180 Mölndal, Sweden.;UCL Inst Neurol, Dept Neurodegenerat Dis, London WC1E 6BT, England.;Hong Kong Ctr Neurodegenerat Dis, Hong Kong, Peoples R China.;Cardiff Univ, Sch Med, UKDRI Cardiff, Cardiff CF14 4YS, Wales.;Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci, Cardiff CF14 4XN, Wales.;Univ Cologne, Dept Psychiat & Psychotherapy, Fac Med, D-50937 Cologne, Germany..
    Blennow, Kaj
    Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, S-43141 Mölndal, Sweden.;Sahlgrens Univ Hosp, Clin Neurochem Lab, SE-43180 Mölndal, Sweden..
    He, Zihuai
    Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA..
    Williams, Julie
    Amouyel, Philippe
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    Jessen, Frank
    Univ Cologne, Dept Psychiat & Psychotherapy, Fac Med, D-50937 Cologne, Germany.;Univ Cologne, Univ Hosp Cologne, D-50937 Cologne, Germany..
    Kehoe, Patrick G.
    IRCCS Santa Lucia Fdn, Lab Neuropsychiat, I-00179 Rome, Italy.;Univ Bristol, Bristol Med Sch, Translat Hlth Sci Bristol, Bristol, Avon, England..
    Andreassen, Ole A.
    Oslo Univ Hosp, Div Mental Hlth & Addict, NORMENT Ctr, N-0450 Oslo, Norway.;Univ Oslo, Inst Clin Med, Oslo, Norway..
    Van Duin, Cornelia
    Univ Oxford, Nuffield Dept Populat Hlth, Oxford OX3 7LF, England.;Alzheimers Ctr Reina Sofia, CIEN Fdn, Madrid, Spain..
    Tsolaki, Magda
    Aristotle Univ Thessaloniki, Sch Med, Dept Neurol 1, Thessaloniki 54124, Greece.;Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada..
    Sanchez-Juan, Pascual
    Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain.;Univ Hlth Network, Krembil Brain Inst, Toronto, ON M5G 2C4, Canada..
    Frikke-Schmidt, Ruth
    Copenhagen Univ Hosp, Rigshospitalet, Dept Clin Biochem, DK-2100 Copenhagen, Denmark..
    Sleegers, Kristel
    VIB, VIB Ctr Mol Neurol, Complex Genet Alzheimers Dis Grp, B-2610 Antwerp, Belgium.;Inst Born Bunge, Lab Neurogenet, B-2610 Antwerp, Belgium.;Univ Antwerp, Dept Biomed Sci, B-2000 Antwerp, Belgium..
    Todau, Tatsushi
    Univ Tokyo, Grad Sch Med, Dept Neurol, Tokyo 1920982, Japan..
    Zettergren, Anna
    Sahlgrens Acad, Ctr Ageing & Hlth AGECAP, Inst Neurosci & Physiol, Neuropsychiatr Epidemiol Unit,Dept Psychiat & Neu, S-43141 Gothenburg, Sweden.;Univ Gothenburg, S-43141 Gothenburg, Sweden..
    Ingelsson, Martin
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Molecular Geriatrics.
    Okada, Yukinori
    Osaka Univ, Grad Sch Med, Dept Stat Genet, Suita, Osaka 5650871, Japan.;Vrije Univ Amsterdam, Amsterdam UMC, Amsterdam Neurosci, Neurochem Lab,Dept Clin Chem, NL-1081 HV Amsterdam, Netherlands.;Copenhagen Univ Hosp, Rigshospitalet, Dept Clin Biochem, DK-2100 Copenhagen, Denmark.;San Gerardo Hosp, Neurol, I-20900 Monza, Italy.;Univ Milano Bicocca, I-20900 Monza, Italy.;Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada.;Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, Toronto, ON M5S 1A8, Canada.;Osaka Univ, Lab Stat Immunol Immunol Frontier Res ctr WPI IIR, Suita, Osaka 5650871, Japan.;Osaka Univ, Integrated Frontier Res Med Sci Div, Inst Open & Transdisciplinary Res Initiat, Suita, Osaka 5650871, Japan.;Osaka Univ, Ctr Infect Dis Educ & Res, Suita, Osaka 5650871, Japan..
    Rossi, Giacomina
    Maastricht Univ, Alzheimer Ctr Limburg, Dept Psychiat & Neuropsychol, NL-6229GS Maastricht, Netherlands.;Fdn IRCCS Ist Neurol Carlo Besta, I-20133 Milan, Italy..
    Hiltunen, Mikko
    Univ Eastern Finland, Inst Biomed, Joensuu 80101, Finland..
    Gim, Jungsoo
    Chosun Univ, Dept Biomed Sci, Gwangju 61452, South Korea.;Chosun Univ, Dept Integrat Biol Sci, Gwangju 61452, South Korea.;Chosun Univ, Cohort Res Ctr, Gwangju Alzheimers & Related Dementias, Gwangju 61452, South Korea..
    Ozaki, Kouichi
    Natl Ctr Geriatr & Gerontol, Med Genome Ctr, Res Inst, Obu 4748511, Japan.;Sahlgrens Acad, Ctr Ageing & Hlth AGECAP, Inst Neurosci & Physiol, Neuropsychiatr Epidemiol Unit,Dept Psychiat & Neu, S-43141 Gothenburg, Sweden.;Univ Gothenburg, S-43141 Gothenburg, Sweden.;RIKEN, Ctr Integrat Med Sci, Yokohama, Kanagawa, Japan..
    Sims, Rebecca
    Sahlgrens Univ Hosp, Psychosis Clin, Reg Vastra Gotaland, S-41345 Gothenburg, Sweden.;Cardiff Univ, Sch Med, Div Psychol Med & Clin Neurosci Sch, Cardiff CF14 4YS, S Glam, Wales..
    Foo, Jia Nee
    Nanyang Technol Univ Singapore, Lee Kong Chian Sch Med, Singapore 308232, Singapore.;ASTAR, Genome Inst Singapore, Lab Neurogenet, Singapore 138672, Singapore..
    van der Fliere, Wiesje
    Vrije Univ Amsterdam, Amsterdam UMC, Alzheimer Ctr Amsterdam, Amsterdam Neurosci,Dept Neurol, NL-1081 HV Amsterdam, Netherlands..
    Ikeuchi, Takeshi
    Niigata Univ, Brain Res Inst, Dept Mol Genet, Niigata 950218, Japan..
    Ramirez, Alfredo
    Univ Cologne, Univ Hosp Cologne, Div Neurogenet & Mol Psychiat, Dept Psychiat & Psychotherapy, D-50937 Cologne, Germany.;Univ Hosp Bonn, Fac Med, Dept Neurodegenerat Dis & Geriatr Psychiat, D-53127 Bonn, Germany.;Univ Med Ctr Goettingen, Dept Psychiat & Psychotherapy, D-37075 Gottingen, Germany.;Alzheimers & Neurodegenerat Dis, Dept Psychiat, San Antonio, TX 78229 USA..
    Mata, Ignacio
    Cleveland Clin, Lerner Res Inst, Gen Med, Cleveland, OH 44196 USA..
    Ruiz, Agustin
    Univ Int Catalunya, Inst Catala Neurociencies Aplicades, Res Ctr & Memory Clin Fundacio ACE, Barcelona 08029, Spain.;Inst Salud Carlos III, Networking Res Ctr Neurodegenerat Dis CIRNED, Madrid 28029, Spain..
    Gan-Or, Ziv
    Neuro Montreal Neurol Inst Hosp, Montreal, PQ H3A 2B4, Canada.;McGill Univ, Dept Human Genet, Montreal, PQ H3A 0G4, Canada.;McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ H3A 0G4, Canada..
    Lambert, Jean-Charles
    Univ Lille, INSERM, CHU Lille,RID AGE U1167, Inst Pasteur Lille,Facteurs Risque & Determinants, F-59000 Lille, France..
    Greicius, Michael D.
    Stanford Univ, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA..
    Mignot, Emmanuel
    Stanford Univ, Ctr Sleep Sci & Med, Palo Alto, CA 94304 USA..
    Multiancestry analysis of the HLA locus in Alzheimer's and Parkinson's diseases uncovers a shared adaptive immune response mediated by HLA-DRB1*04 subtypes2023In: Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, E-ISSN 1091-6490, Vol. 120, no 36, article id e2302720120Article in journal (Refereed)
    Abstract [en]

    Across multiancestry groups, we analyzed Human Leukocyte Antigen (HLA) associations in over 176,000 individuals with Parkinson's disease (PD) and Alzheimer's disease (AD) versus controls. We demonstrate that the two diseases share the same protective association at the HLA locus. HLA-specific fine-mapping showed that hierarchical protective effects of HLA-DRB1*04 subtypes best accounted for the association, strongest with HLA-DRB1*04:04 and HLA-DRB1* 04:07, and intermediary with HLA-DRB1* 04:01 and HLA- DRB1*04:03. The same signal was associated with decreased neurofibrillary tangles in postmortem brains and was associated with reduced tau levels in cerebrospinal fluid and to a lower extent with increased A beta 42. Protective HLA-DRB1*04 subtypes strongly bound the aggregation-prone tau PHF6 sequence, however only when acetylated at a lysine (K311), a common posttranslational modification central to tau aggregation. An HLA-DRB1*04-mediated adaptive immune response decreases PD and AD risks, potentially by acting against tau, offering the possibility of therapeutic avenues.

    Download full text (pdf)
    fulltext
  • 22.
    Neumann, Johannes Tobias
    et al.
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Martinistr 52, D-20246 Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany.;German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany.;Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Australia..
    Twerenbold, Raphael
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany.;German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany..
    Weimann, Jessica
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany..
    Ballantyne, Christie M.
    Baylor Coll Med, Dept Med, Ctr Cardiometab Dis Prevent, Houston, TX 77030 USA..
    Benjamin, Emelia J.
    Boston Univ, Boston Med Ctr, Chobanian & Avedisian Sch Med, Dept Pediat, Boston, MA USA.;Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA USA..
    Costanzo, Simona
    IRCCS Neuromed, Dept Epidemiol & Prevent, Pozzilli, Italy..
    de Lemos, James A.
    UT Southwestern Med Ctr, Dept Internal Med, Dallas, TX USA..
    Defilippi, Christopher R.
    Inova Heart & Vasc Inst, Falls Church, VA USA..
    Di Castelnuovo, Augusto
    Mediterranea Cardioctr, Naples, Italy..
    Donfrancesco, Chiara
    Natl Inst Hlth, Dept Cardiovasc Endocrine Metab Dis & Aging, I-00199 Rome, Italy..
    Doerr, Marcus
    Univ Greifswald, Dept Internal Med B, D-17487 Greifswald, Germany.;Univ Med Greifswald, Partner Site Greifswald, DZHK German Ctr Cardiovasc Res, Greifswald, Germany..
    Eggers, Kai M.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.
    Engstroem, Gunnar
    Lund Univ, Dept Clin Sci, Malmö, Sweden..
    Felix, Stephan B.
    Univ Greifswald, Dept Internal Med B, D-17487 Greifswald, Germany.;Univ Med Greifswald, Partner Site Greifswald, DZHK German Ctr Cardiovasc Res, Greifswald, Germany..
    Ferrario, Marco M.
    Univ Insubria, Res Ctr Epidemiol & Prevent Med, Dept Med & Surg, Varese, Italy..
    Gansevoort, Ron T.
    Univ Med Ctr Groningen, Dept Nephrol, Groningen, Netherlands..
    Giampaoli, Simona
    Ist Super San, Rome, Italy..
    Giedraitis, Vilmantas
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Hedberg, Pär
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Disciplinary Domain of Medicine and Pharmacy, research centers etc., Centre for Clinical Research, County of Västmanland.
    Iacoviello, Licia
    IRCCS Neuromed, Dept Epidemiol & Prevent, Pozzilli, Italy.;Libera Univ Mediterranea Giuseppe DEGENNARO, Dept Med & Surg, I-70010 Casamassima, Italy..
    Jorgensen, Torben
    Univ Copenhagen, Fac Hlth & Med Sci, Dept Publ Hlth, Copenhagen, Denmark.;Bispebjerg Hosp, Ctr Clin Res & Prevent, Copenhagen, Denmark..
    Kee, Frank
    Queens Univ Belfast, UKCRC Ctr Excellence Publ Hlth, Belfast, Antrim, North Ireland..
    Koenig, Wolfgang
    Tech Univ Munich, German Heart Ctr, D-80636 Munich, Germany.;Univ Ulm, Inst Epidemiol & Med Biometry, Ulm, Germany.;German Ctr Cardiovasc Dis Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany..
    Kuulasmaa, Kari
    Finnish Inst Hlth & Welf, Helsinki, Finland..
    Lewis, Joshua R.
    Edith Cowan Univ, Nutr & Hlth Innovat Res Inst, Sch Med & Hlth Sci, Perth, Australia.;Univ Western Australia, Med Sch, Perth, Australia.;Childrens Hosp Westmead, Ctr Kidney Res, Sydney, NSW, Australia..
    Lorenz, Thiess
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany..
    Lyngbakken, Magnus N.
    Akershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway.;Univ Oslo, Dept Pharmacol, Inst Clin Med, Fac Med, Oslo, Norway..
    Magnussen, Christina
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany.;German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany..
    Melander, Olle
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.
    Nauck, Matthias
    Univ Med Greifswald, Partner Site Greifswald, DZHK German Ctr Cardiovasc Res, Greifswald, Germany.;Univ Med Greifswald, Inst Clin Chem & Lab Med, Greifswald, Germany..
    Niiranen, Teemu J.
    Finnish Inst Hlth & Welf, Helsinki, Finland.;Turku Univ Hosp, Div Med, Turku, Finland.;Univ Turku, Dept Internal Med, Turku, Finland..
    Nilsson, Peter M.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Cardiology.
    Olsen, Michael H.
    Holbaek Sygehus, Dept Internal Med, Cardiol Sect, Holbaek, Denmark.;Univ Southern Denmark, Dept Reg Hlth Res, Odense, Denmark..
    Omland, Torbjorn
    Akershus Univ Hosp, Dept Cardiol, Div Med, Lorenskog, Norway.;Univ Oslo, Dept Pharmacol, Inst Clin Med, Fac Med, Oslo, Norway..
    Oskarsson, Viktor
    Umeå Univ, Dept Publ Hlth & Clin Med, Sect Med, Umeå, Sweden..
    Palmieri, Luigi
    Natl Inst Hlth, Dept Cardiovasc Endocrine Metab Dis & Aging, I-00199 Rome, Italy..
    Peters, Anette
    German Ctr Cardiovasc Dis Res DZHK, Partner Site Munich Heart Alliance, Munich, Germany.;Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany.;Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany..
    Prince, Richard L.
    Edith Cowan Univ, Nutr & Hlth Innovat Res Inst, Sch Med & Hlth Sci, Perth, Australia.;Univ Western Australia, Med Sch, Perth, Australia..
    Qaderi, Vazhma
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany..
    Vasan, Ramachandran S.
    Boston Univ, Boston Med Ctr, Chobanian & Avedisian Sch Med, Dept Pediat, Boston, MA USA.;Univ Texas, Hlth Sci Ctr, Sch Publ Hlth, San Antonio, TX 78284 USA..
    Salomaa, Veikko
    Finnish Inst Hlth & Welf, Helsinki, Finland..
    Sans, Susana
    Catalan Dept Hlth, Barcelona, Spain..
    Smith, J. Gustav
    Univ Gothenburg, Inst Med, Dept Mol & Clin Med, Wallenberg Lab, Gothenburg, Sweden..
    Soederberg, Stefan
    Umeå Univ, Dept Publ Hlth & Clin Med, Sect Med, Umeå, Sweden..
    Thorand, Barbara
    Helmholtz Zentrum Munchen, Inst Epidemiol, German Res Ctr Environm Hlth, Neuherberg, Germany.;Ludwig Maximilians Univ Munchen, Fac Med, Inst Med Informat Proc Biometry & Epidemiol, Munich, Germany..
    Tonkin, Andrew M.
    Monash Univ, Sch Publ Hlth & Prevent Med, Dept Epidemiol & Prevent Med, Melbourne, Australia..
    Tunstall-Pedoe, Hugh
    Univ Dundee, Cardiovasc Epidemiol Unit, Inst Cardiovasc Res, Dundee, Scotland..
    Veronesi, Giovanni
    Univ Insubria, Res Ctr Epidemiol & Prevent Med, Dept Med & Surg, Varese, Italy..
    Watanabe, Tetsu
    Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata, Japan..
    Watanabe, Masafumi
    Yamagata Univ, Sch Med, Dept Cardiol Pulmonol & Nephrol, Yamagata, Japan..
    Zeiher, Andreas M.
    Goethe Univ, Inst Cardiovasc Regenerat, Frankfurt, Germany.;German Ctr Cardiovasc Res DZHK, Partner Site Rhine Main, Mainz, Germany..
    Zeller, Tanja
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany.;German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany..
    Blankenberg, Stefan
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany.;German Ctr Cardiovasc Res, Partner Site Hamburg Kiel Lubeck, Hamburg, Germany..
    Ojeda, Francisco
    Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Dept Cardiol, Hamburg, Germany.;Univ Med Ctr Hamburg Eppendorf, Univ Heart & Vasc Ctr Hamburg, Ctr Populat Hlth Innovat, Hamburg, Germany..
    Prognostic Value of Cardiovascular Biomarkers in the Population2024In: Journal of the American Medical Association (JAMA), ISSN 0098-7484, E-ISSN 1538-3598, Vol. 331, no 22, p. 1898-1909Article in journal (Refereed)
    Abstract [en]

    Importance Identification of individuals at high risk for atherosclerotic cardiovascular disease within the population is important to inform primary prevention strategies. Objective To evaluate the prognostic value of routinely available cardiovascular biomarkers when added to established risk factors. Design, Setting, and Participants Individual-level analysis including data on cardiovascular biomarkers from 28 general population-based cohorts from 12 countries and 4 continents with assessments by participant age. The median follow-up was 11.8 years. Exposure Measurement of high-sensitivity cardiac troponin I, high-sensitivity cardiac troponin T, N-terminal pro-B-type natriuretic peptide, B-type natriuretic peptide, or high-sensitivity C-reactive protein. Main Outcomes and Measures The primary outcome was incident atherosclerotic cardiovascular disease, which included all fatal and nonfatal events. The secondary outcomes were all-cause mortality, heart failure, ischemic stroke, and myocardial infarction. Subdistribution hazard ratios (HRs) for the association of biomarkers and outcomes were calculated after adjustment for established risk factors. The additional predictive value of the biomarkers was assessed using the C statistic and reclassification analyses. Results The analyses included 164 054 individuals (median age, 53.1 years [IQR, 42.7-62.9 years] and 52.4% were women). There were 17 211 incident atherosclerotic cardiovascular disease events. All biomarkers were significantly associated with incident atherosclerotic cardiovascular disease (subdistribution HR per 1-SD change, 1.13 [95% CI, 1.11-1.16] for high-sensitivity cardiac troponin I; 1.18 [95% CI, 1.12-1.23] for high-sensitivity cardiac troponin T; 1.21 [95% CI, 1.18-1.24] for N-terminal pro-B-type natriuretic peptide; 1.14 [95% CI, 1.08-1.22] for B-type natriuretic peptide; and 1.14 [95% CI, 1.12-1.16] for high-sensitivity C-reactive protein) and all secondary outcomes. The addition of each single biomarker to a model that included established risk factors improved the C statistic. For 10-year incident atherosclerotic cardiovascular disease in younger people (aged <65 years), the combination of high-sensitivity cardiac troponin I, N-terminal pro-B-type natriuretic peptide, and high-sensitivity C-reactive protein resulted in a C statistic improvement from 0.812 (95% CI, 0.8021-0.8208) to 0.8194 (95% CI, 0.8089-0.8277). The combination of these biomarkers also improved reclassification compared with the conventional model. Improvements in risk prediction were most pronounced for the secondary outcomes of heart failure and all-cause mortality. The incremental value of biomarkers was greater in people aged 65 years or older vs younger people. Conclusions and Relevance Cardiovascular biomarkers were strongly associated with fatal and nonfatal cardiovascular events and mortality. The addition of biomarkers to established risk factors led to only a small improvement in risk prediction metrics for atherosclerotic cardiovascular disease, but was more favorable for heart failure and mortality.

  • 23.
    Nordström, Anna
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. UiT Arctic Univ Norway, Sch Sport Sci, Tromso, Norway..
    Nordström, Peter
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Impaired Balance Predicts Cardiovascular Disease in 70-Year-Old Individuals-An Observational Study From the Healthy Aging Initiative2024In: Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, E-ISSN 2047-9980, Vol. 13, no 19, article id e035073Article in journal (Refereed)
    Abstract [en]

    Background: Limited research has explored balance problems as a prospective risk factor for cardiovascular disease (CVD). This study aimed to characterize the association between balance measures and the risk of incident CVD in a population of 70-year-olds.

    Methods and Results: From 2012 to 2022 a cohort of 4927 older individuals who were CVD free underwent balance assessments using a balance board. Measurements included lateral and anterior-posterior sway, along with a safety limit of stability in a subcohort (N=2782). Time to first hospitalization for CVD, encompassing stroke, myocardial infarction, or angina pectoris was the primary outcome. Multivariable regression models assessed associations between balance parameters and CVD risk. Over a mean follow-up of 4.9 years, 320 individuals were hospitalized for CVD. In a balance test with eyes open, increased lateral sway at baseline was associated with a higher risk of CVD (hazard ratio [HR], 1.014 [95% CI, 1.004-1.025], P=0.005, per mm increased sway), after adjustment for traditional risk factors for CVD. Similarly, individuals with CVD during follow-up exhibited higher lateral sway with eyes closed at baseline (HR, 1.015 [95% CI, 1.005-1.025], P=0.002, per mm increased sway), after multivariable adjustment. The 4 strongest independent predictors of CVD included lateral sway and were associated with a population attributable fraction of 61% (95% CI, 54-68).

    Conclusions: In community-dwelling 70-year-olds, impaired lateral balance was an independent predictor of later CVD, after adjustment for traditional risk factors. This may suggest that position balance could be used as an early risk marker for underlying atherosclerotic disease.

    Download full text (pdf)
    fulltext
  • 24.
    Nordström, Peter
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Ahlqvist, Viktor H.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Aarhus Univ, Dept Biomed, Aarhus, Denmark.;Karolinska Inst, Inst Environm Med, Stockholm, Sweden..
    Ballin, Marcel
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics. Ctr Epidemiol & Community Med, Stockholm, Stockholm, Sweden..
    Nordström, Anna
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Medical Sciences, Rehabilitation Medicine. Arctic Univ Norway, UiT, Sch Sport Sci, Tromso, Norway..
    A novel clinical prediction model for hip fractures: a development and validation study in the total population of Sweden2024In: eClinicalMedicine, E-ISSN 2589-5370, Vol. 77, article id 102877Article in journal (Refereed)
    Abstract [en]

    Background Low bone density and osteoporosis are indications for bone-specific fi c treatment. However, given the limited availability of bone density data in clinical practice and the fact that most patients with hip fracture do not have osteoporosis, accurate prediction of hip fracture risk in the absence of bone density data would be crucial. Methods This development and validation study included the entire Swedish population aged 50 years or older in 2005 (N = 3,340,977) and was conducted by cross-linking data from nationwide registers. Potential predictive variables included diagnoses, prescription medications, familial factors, frailty-related factors, and socioeconomic factors. The primary endpoint was the 5-year risk of hip fracture. Fracture prediction algorithms were developed and validated using multivariable models. Model performance and validation was also examined in a sub cohort restricted to 504,431 individuals with non-Swedish background. Findings During a total follow-up of 15.2 million person-years, 87,089 individuals suffered a hip fracture within 5 years. In the fi nal prediction model, 19 variables were associated with a population attributable fraction of 93.9% (95% CI, 93.7-94.1) - 94.1) in women and 92.7% (95% CI, 92.2-93.0) - 93.0) in men. The strongest predictor, besides old age, was the use of homemaker service, with a 5-year risk of hip fracture of 7.8% in women and 4.7% in men. The diagnoses most strongly predicting the 5-year risk of hip fracture was Parkinson's ' s disease (6.8% in women, 4.6% in men) and dementia (6.1% in women, 3.6% in men). Validation of the prediction model suggested that the optimal threshold for treatment with bone-specific fi c agents was an estimated 5-year hip fracture risk of 3%. Assuming a threshold of 3% and a 30% relative risk reduction from bone-specific fi c treatment, the number needed to treat to prevent one hip fracture was estimated to 36 in women and 52 in men. Similar results were obtained in the sub cohort with non-Swedish background. Interpretation A clinical prediction model developed and validated in the total Swedish population could predict the risk of hip fractures with high precision even in absence of data on bone density. The model was associated with a population attributable fraction for hip fracture of more than 90%, and the strongest predictor besides old age was the use of homemaker service, which likely reflect fl ect frailty. Based on the model, individuals with an estimated 5-year risk of hip fracture of at least 3% could be considered for bone-specific fi c treatment. Funding None. Copyright (c) 2024 The Author(s). Published by Elsevier Ltd. This is an open access article under the CC BY license (http://creativecommons.org/licenses/by/4.0/). 2024;77: Published https://doi.org/10. 1016/j.eclinm.2024. 102877

    Download full text (pdf)
    fulltext
  • 25.
    Olsson, Jan
    et al.
    Umeå Univ, Dept Clin Microbiol, Umeå, Sweden..
    Nourmohammadi, Sema
    Umeå Univ, Dept Clin Microbiol, Umeå, Sweden..
    Honkala, Emma
    Umeå Univ, Dept Clin Microbiol, Umeå, Sweden..
    Johansson, Anders
    Umeå Univ, Dept Odontol, S-90197 Umeå, Sweden..
    Hallmans, Göran
    Umeå Univ, Dept Publ Hlth & Clin Med, Umeå, Sweden..
    Weidung, Bodil
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Clinical geriatrics.
    Lövheim, Hugo
    Umeå Univ, Dept Community Med & Rehabil, Geriatr Med, Umeå, Sweden..
    Elgh, Fredrik
    Umeå Univ, Dept Clin Microbiol, Umeå, Sweden..
    Time trends in herpesvirus seroepidemiology among Swedish adults2024In: BMC Infectious Diseases, E-ISSN 1471-2334, Vol. 24, article id 273Article in journal (Refereed)
    Abstract [en]

    Background: Human herpesviruses are widespread among the human population. The infections often occur unnoticed, but severe disease as well as long-term sequelae are part of the symptom spectrum. The prevalence varies among subpopulations and with time. The aim of this study was to describe the seroprevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2, Epstein-Barr virus and Cytomegalovirus in the adult Swedish population over a time period of several decades.

    Methods: Serum samples (n = 892) from biobanks, originating from 30-year-old women, 50-year-old men and 50-year-old women sampled between 1975 and 2018, were analyzed for presence of anti-herpesvirus antibodies. Linear regression analysis was used to test for a correlation between birth year and seroprevalence. Multiple linear regression analysis was used to differentiate between other factors such as age and gender.

    Results: Birth year correlated negatively with the prevalence of immunoglobulin G against Herpes simplex 1 and Epstein-Barr virus (p = 0.004 and 0.033), and positively with Immunoglobulin G against Cytomegalovirus (p = 0.039). When participant categories were analyzed separately, birth year correlated negatively with the prevalence of Immunoglobulin G against Herpes simplex 1 and Herpes simplex 2 (p = 0.032 and 0.028) in 30-year-old women, and with the prevalence of Immunoglobulin G against Cytomegalovirus in 50-year-old men (p = 0.011).

    Conclusions: The prevalence of Immunoglobulin G against Herpes simplex 1, Herpes simplex 2 and Epstein-Barr virus decreases in later birth cohorts. This indicates a trend of declining risk of getting infected with these viruses as a child and adolescent.

    Download full text (pdf)
    FULLTEXT01
  • 26.
    Pagnon de la Vega, María
    et al.
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Molecular Geriatrics.
    Syvänen, Stina
    Uppsala University, Disciplinary Domain of Medicine and Pharmacy, Faculty of Medicine, Department of Public Health and Caring Sciences, Molecular Geriatrics.
    Giedraitis, Vilmantas